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resumo  
As doenças cardiovasculares são a principal causa de morte em todo o 
mundo. De entre estas, o enfarte do miocárdio é uma das doenças mais 
comuns, sendo caracterizado por isquemia que leva a morte de células 
cardíacas. A isquemia ocorre em consequência da privação simultânea de 
nutrientes e oxigénio. Enquanto a isquemia representa um dano celular, a 
privação de nutrientes está relacionada com efeitos cardioprotetores. A 
resposta das células a estes estímulos pode ser por indução de autofagia ou de 
apoptose, dependendo da sua capacidade de adaptação e resposta aos fatores 
indutores de isquemia. A autofagia é um processo auto-degradativo que 
permite à célula adaptar-se ao stresse e é, portanto, um processo associado à 
sobrevivência celular. A libertação de exossomas pelas células é também um 
mecanismo de adaptação cujas funções estão relacionadas com a 
comunicação intercelular. Por outro lado, a apoptose é um processo de morte 
celular programada. A regulação destes processos é de extrema importância 
para a sobrevivência e recuperação nos episódios de enfarte do miocárdio.  
     Hoje em dia sabe-se que os lípidos têm um papel importante no 
desenvolvimento de doenças cardiovasculares embora o seu papel ainda não 
esteja completamente esclarecido. Os lípidos são os componentes maioritários 
da membrana celular e desempenham funções a nível estrutural e de 
sinalização. Quando exposto a diversas condições fisiopatológicas, o 
conteúdo lipídico das células e dos exossomas é modificado. No entanto, 
existem ainda poucas publicações sobre a avaliação do lipidoma de 
cardiomiócitos em patologias cardiovasculares. Assim, o objetivo principal 
deste trabalho é identificar alterações no perfil lipídico de cardiomiócitos e 
exossomas libertados por estes sob privação de nutrientes e de oxigénio, de 
forma a melhor compreender o enfarte do miocárdio e se possível identificar 
novos biomarcadores para esta patologia.  
    
apoptose, autofagia, biomarcadores, cardiomiócitos, doenças 
cardiovasculares, espectrometria de massa, exossomas, fosfolípidos, infarte 
do miocárdio, isquémia, lipidómica 
Nas células cardíacas verificamos que algumas espécies moleculares de 
fosfatidilcolina (PC34:1 e PC36:2), fosfatidiletanolamina (PE34:1), 
fosfatidilserina (PS36:1), fosfatidilinositol (PI36:2, PI38:3 e PI38:5) e 
esfingomielina (SM34:1) variam em isquemia e em privação de nutrientes em 
comparação com o controlo. Algumas variações foram específicas da 
privação de nutrientes como a diminuição de SM(34:1) e o aumento de 
PS(36:1) e outras foram específicas da isquemia como a diminuição de 
PC(36:2) e de LPC(16:0). A espécie molecular PC(34:1) foi a que se mostrou 
alterada de forma diferente em cada condição sendo que aumenta em caso de 
isquemia e diminui em caso da privação de nutrientes. 
No caso dos exossomas, os resultados obtidos permitiram verificar que houve 
um maior desvio entre o lipidoma de exossomas libertado em isquemia e 
privação de nutrientes em todas as classes de lípidos. Algumas alterações 
foram coincidentes com as observadas para as células, por exemplo a 
diminuição PC(34:1) em starvation mas outras foram diferentes. Uma vez que 
apenas se realizaram análises lipdómicas para uma dimensão reduzida de 
amostra de exossomas, serão necessários estudos futuros para a validação dos 
resultados obtidos. 
Em conclusão, a privação de nutrientes e a isquemia induzem alterações na 
homeostasia dos lípidos. Este trabalho sugere que os lípidos são potenciais 
ferramentas para avaliar se os cardiomiócitos estão a optar pela morte celular 
ou pela recuperação, que serão úteis para melhorar o diagnóstico e 
prognóstico de doenças cardiovasculares. 
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Abstract              
Cardiovascular Diseases are the most significant cause of death. Myocardium 
infarction is one of the most common of this type of diseases and it is 
characterized by myocardium ischemia. Ischemia occurs in consequence of 
simultaneous starvation and hypoxia. While ischemia represents a cellular 
damage, starvation is associated with a cardioprotective effect. The cell 
response to this injury includes either autophagy or apoptosis depending on 
the ability to adapt and respond to the injury and is very important for the 
evolution and recovery of the myocardium infarction. Autophagy is a self-
degradative process that allows cell to adapt to stress and so it is associated 
with cell survival. The exosomes release by cardiomyocytes is also an 
adaptive process which functions are related with intercellular 
communication. On the other hand, apoptosis is a process of programmed cell 
death.  
     It is well known that lipids play an important role in cardiovascular disease 
although their role is not completely understood. Lipids are the major 
component of a cell membrane and play structural and signaling roles. Under 
several physiopathological conditions, the cell and exosomes lipid content 
can be modified. However reports on lipidome of cardiomyocytes under 
cardiovascular diseases are scarce. Thus, the primary aim of this work is to 
identify lipid profile changes in cardiomyocytes and exosomes released by 
them under starvation and ischemia, in order to better understand myocardial 
infarction and if possible to recognize new biomarkers for myocardial 
infarction. 
Cardiac cells showed that molecular species alterations in 
phosphatidylcholine (PC34:1 and PC36:2), phosphatidylethanolamine 
(PE34:1), phosphatidylserine (PS36:1), phosphatidylinositol (PI36:2, PI38:3 
and PI38:5) and sphingomyelin (SM34:1) were changed in ischemia and in 
starvation in comparison with control group. Some differences were specific 
of starvation as  the decrease in SM(34:1) and the increase in PS(36:1) while 
apoptosis, autophagy, biomarkers, cardiomyocytes, cardiovascular diseases, 
exosomes, ischemia, lipidomics,  mass spectrometry, myocardial infarction, 
phospholipids, starvation 
others were specific of ischemia as the decrease in PC(36:2) and LPC(16:0). 
The molecular specie PC(34:1) showed different alterations in each condition 
increasing in case of ischemia and decreasing in case of starvation.  
 For exosomes, our results showed a deviation between the lipidome of 
exosomes released upon ischemia and starvation for all lipid classes. Some 
differences matched the ones observed in cells, for example the decrease in 
PC(34:1) in starvation, but others were different. Since we have only 
performed lipidomic analysis for a smaller sample of exosomes, it requires 
further studies to validate the results. 
In conclusion, ischemia and starvation induced changes in lipid homeostasis. 
Our work suggests that lipids are potential tools for evaluation of cell fate, 
either cell death or recovery, that will be useful to improve diagnosis and 
prognostic of cardiovascular diseases. 
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Introduction 
 Cardiovascular Diseases 
Cardiovascular diseases are the most significant cause of death all over the world. 
An accurate diagnosis is essential to early therapeutic intervention and to prevent further 
complications. Due to the lack of specific and sensitive tests, it is somehow difficult to 
do an early diagnosis to be beneficial to those presenting this debilitating condition.  
The mortality rate of cardiovascular diseases has decreased in the last two decades 
(Figure 1) due to contribution of three conjugated factors [1]. First is the adoption of 
preventive strategies such as reduced smoke tobacco, exercise and a healthy diet. 
Second is the improvement of diagnosis and adjustment of modifiable risk factors [4]. 
The third is the significant advance in treatment not only by the increased availability of 
drugs but also by the upgrade of administrative conditions allowing better target 
locations where treatment can be administered [1]. Even though the morbidity and 
mortality associated to this group of disease is still very high and need to be reverted. 
 
Figure 1. Cardiovascular Disease Mortality Rate in Europe and Portugal (INE). 
 
Cardiovascular diseases include two major groups of diseases: cerebrovascular 
disease and ischemic heart diseases (IDH). IDH are the most prevalent in world 
population and myocardial infarction is the most relevant disease among this category 
(Figure 2).  
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Figure 2. Prevalence of different cardiovascular diseases in the world (WHO). 
 
Myocardium infarction is one of the most common IHD, which are characterized by 
ischemia. Ischemia is described as the reduced blood, and thus in a shortage of oxygen 
and nutrients, supply to the heart due to narrowing of the arteries. The narrowing of the 
arteries is a characteristic of atherosclerosis which is described as the thickening and 
hardening of the artery walls caused by deposits of cholesterol-lipid-calcium plaque. 
Therefore, atherosclerosis is a major cause of ischemia and consequently ischemic heart 
diseases [2]. The atherosclerosis is an inflammatory chronic disorder wherein 
endothelial lesions and accumulation of fat and cells obstruct the vascular lumen and 
weaken the underlying smooth muscle causing severe damages. Ischemia can be the 
cause of angina pectoris, chronic heart failure (CHF), hypertensive heart disease (HHD) 
and myocardial infarction (MI) (Scheme 1) [3]. 
 
Scheme 1. Different ischemic heart diseases with atherosclerosis as a cause. 
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Angina Pectoris, referred as cardiac chest pain, is not simply one type of pain but a 
group of symptoms related to cardiac ischemia. It usually begins gradually and last only 
a few minutes. Angina can either occur in rest or be brought by effort [4]. Chronic Heart 
Failure (CHF) is referred to some structural or functional cardiac disorders that impair 
the ability of the ventricle to fill with or eject blood. CHF may result from disorders of 
the heart walls, such as myocardium, or from disorders of the great vessels. However, 
most of the cases are due to left ventricular dysfunction. Hypertensive Heart Disease is 
a term referring to heart diseases caused by direct or indirect effects of elevated blood 
pressure. It increases the amount of work of the ventricle resulting in hypertrophy and 
dilatation, increasing the arterial pressure and enhancing hypertension. Myocardial 
Infarction (MI) is defined as necrosis of myocardium due to prolonged ischemia. 
Pathologically it includes acute, healing and healed myocardial infarction [2]. 
The diagnostic of the IHD related diseases, including myocardial infarction, the 
most common IHD and thus will be considered herein,  are associated with difficult 
early diagnostic due to the inexistence of very sensitive and specific markers in the first 
hours of the events. Several enzymes are released from the injured tissues that lead to 
increased serum levels. Thus, it can be used as markers for this pathology. Despite the 
lack of tissue specificity, few proteins have clinical significance in the cardiac muscle 
and thus in MI,  such as  lactate dehydrogenase (LDH), aspartate transaminase (AST), 
creatine kinase (CK) and troponin (Tn) [5]. These marks only show up hours after the 
cardiac event and allow confirming MI diagnosis and evaluate it prognosis. Sometimes 
this prevent to perform a correct diagnosis and to implement a correct therapeutics. 
Thus, there is a need for searching new cellular markers to improve the early diagnosis 
of IHD. Lipids have emerged as a plausible hypothesis to this lack of primary markers. 
It is therefore necessary understand the alterations in cardiomyocytes at a molecular 
level and the underlying signaling process. 
1.1.  Myocardial Infarction: Physiopathology 
The myocardial infarction is a major cause of death and disability worldwide. 
Formerly, there was a consensus for the syndrome myocardial infarction. The World 
Health Organization (WHO) defined MI based on symptoms, ECG changes and cardiac 
enzymes. However, with the improvement of more sensitive cardiac markers and more 
sensitive imaging techniques it was possible to detect small amounts of myocardial 
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injury. For that reason, it was required an updated definition of MI. In 2000, the First 
Global MI Task Force presented a new definition of MI suggesting that any necrosis in 
the setting of myocardial ischemia should be considered MI [6]. In 2007, these 
principles were refined by the Second Global MI Task Force. The universal definition 
of myocardial infarction consensus document highlighted the different conditions which 
might lead to a MI. This document was well accepted by the medical community and 
was adopted by the WHO [7]. Though, the development of even more sensitive markers 
mandates additional revision, particularly when necrosis occurs in the setting of the 
critically ill, after coronary procedures or after cardiac surgery. Thus in 2012, the Third 
Global MI Task Force integrate this new insights and recognize that very small amounts 
of myocardial injury can be detected by biochemical markers, preferentially troponin, 
and imaging [8]. 
Nowadays, the MI diagnosis is based on clinical features, including symptoms, 
electrocardiographic (ECG) deviations, and elevated values of biochemical markers and 
by imaging. The symptomatology of MI includes chest pain, at effort or at rest, dyspnea, 
fatigue, and usually takes less than twenty minutes. Frequently, the discomfort is diffuse 
and it may be accompanied by diaphoresis, nausea or syncope. MI may even occur 
without symptoms, called silent myocardial infarction. Dynamic changes in the ECG 
waveforms occur during acute myocardial ischemic episodes and often require the 
acquisition of multiple ECG performed at fifteen to thirty minutes intervals, but these 
changes are not always easily perceptible, making difficult the MI diagnosis [8]. The 
serum biomarkers in acute cardiac diseases can be classified as established, outdated 
and developing. Among these, troponin (cTn) has been established as fundamental for 
diagnosis and also provides strong prognostic information [9]. This protein is 
responsible for the regulation of muscle contraction. Whether cTnI or cTnT, both are 
highly specific to myocardial muscle and so sensitive for cardiac injury. The cTn 
elevations begin two to four hours after onset of symptoms. There are novel data 
suggesting that re-elevations of cTn and an increasing pattern can be used to estimate 
whether a given MI event is acute or is chronic. Other markers are creatine kinase-MB 
(CK-MB), myoglobin and aspartate transaminase (AST). CK-MB is a protein that could 
be used to define infarct timing although clinicians become more comfortable with cTn. 
Myoglobin has been used with the intent of shortening the time to a more definitive 
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diagnosis in patients with chest pain, but it lacks specificity, since it is also abundant in 
muscle and can be elevated in muscle lesions or other myopathies. AST levels begin to 
rise within six to eight hours, peak at twenty-four hours and return to normal within 5 
days. However, because of the extensive tissue distribution, these levels are not useful 
in diagnosis of myocardial infarction. The c-reactive protein (CRP) and the B-type 
natriuretic peptide (BNP) are two developing markers. Some authors argue that, in the 
absence of acute illness, including myocardial injury, levels of CRP are stable. BNP is a 
peptide released in response to cardiac stretch. It is helpful for the detection of 
congestive heart failure in patients with uncertain cause of dyspnea. The routine use of 
this to developing markers is not supported [10]. Commonly used imaging techniques in 
acute and chronic infarction are echocardiography, radionuclide ventrilography, 
myocardial perfusion scintigraphy (MPS) using single proton emission computed 
tomography (SPECT) and magnetic resonance imaging (MRI). Positron emission 
tomography (PET) and x-ray computed tomography (CT) are less common. Each of the 
techniques can assess myocardial viability, perfusion and function [11]. 
Pathologically MI is categorized as acute, healing and healed. Acute MI is 
characterized by the presence of polymorphonuclear leukocytes. Healing MI is 
characterized by the presence of mononuclear cells and fibroblasts and absence of 
polymorphonuclear leukocytes. Healed MI is characterized by scar tissue without 
cellular infiltration [2].  
According to pathological and clinical features, and prognostic differences, along 
with different treatment strategies, myocardial infarction is classified into five types. 
Type 1 is spontaneous myocardial infarction which is related to atherosclerotic plaque 
with resulting thrombus leading to decreased myocardial blood flow. Type 2 is 
myocardial infarction secondary to an ischemic imbalance. There is an imbalance 
between myocardial oxygen supply and demand. Type 3 is myocardial infarction 
resulting in cardiac death but when biomarker values are unavailable. There are 
symptoms suggestive of myocardial ischemia and ECG changes but death occurred 
before blood samples could be obtained, before cardiac markers could rise or cardiac 
markers were not collected. Type 4 and type 5 are related to myocardial infarction 
associated with revascularization procedures. Periprocedural myocardial injury or 
infarction may occur at some stages in the instrumentation of the heart that is required 
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during mechanical revascularization procedures. Following this procedures are elevated 
troponin values since various insults may occur that can lead to myocardial injury with 
necrosis [8].  
Myocardium infarction is one of the most common IHD. These diseases are 
characterized by ischemia, a biological conditions that includes starvation and hypoxia. 
Cells exposed to these conditions have two alternatives: survive, and for that initiates 
the autophagy process; or die and in this case initiates apoptosis. 
 
Scheme 2. Adaptative and non-adapatative cell response to an ischemic event. 
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stress, and increase of reactive oxygen species (ROS) production may occur being one 
of the plausible mechanism that underlie cell apoptosis [16]. 
Starvation of specific nutrient triggers different responses in tissues [12]. Cell 
detects levels of energy by sensing ATP and aminoacids levels. ATP is mainly produced 
by mitochondrial oxidative phosphorylation and during starvation, with the intention of 
meet cellular energy requirement. It is reported an increase in mitochondrial 
proliferation along with decrease in maturation. This indicates that mitochondrial defect 
cannot be compensated by the increase in mitochondrial number [17]. So the lack of 
glucose, that is necessary to maintain ATP levels, leads to the activation of AMPK, 
which is sensitive to AMP:ATP ratio. This activation increases the translocation of 
glucose transporter to the plasma membrane and inhibits promoters of glucose-repressed 
genes. Additionally it activates p53 in order to inhibit cell proliferation [18]. The lack of 
aminoacids such as glutamine and leucine leads to the inhibition of mTORC resulting in 
inhibition of protein synthesis. Moreover, it leads to the decrease of cdc2 activity 
stopping cell cycle and inducing autophagy, a way to help the cell survive. In 
conclusion, cell response when confronted with lack of nutrients by shifting to 
catabolism in hope to survive [12]. 
 Autophagy as a way of cell survival 
Autophagy is seen as a self-degradative process important not only for 
housekeeping but for balancing sources of energy in response to nutrient stress. It 
initiates with a phagophore derived from lipid bilayer that expands to engulf intra-
cellular cargo. The loaded double-membrane autophagosome matures through fusion 
with the lysosome, leading to the degradation of autophagosomal contents by acid 
proteases. This process promotes cellular senescence, protects against genome 
instability and prevents necrosis, giving it a key role in preventing diseases such as 
neurodegeneration, cardiomyopathy and diabetes [13].  
Two hypotheses have emerged: is autophagy assisting in the death of cells or is it 
protecting the cell from it? Since autophagy promotes cell survival during nutrient 
starvation and it may also indirectly promote cell survival by retarding or preventing 
apoptosis, and it seems that the correct hypothesis in these circumstances is the second 
one. In the heart, autophagy is low under normal conditions but it is enhanced in 
 24 
 
Introduction 
pathophysiological conditions, such as in the case of ischemia that is associated with 
ATP depletion and increased ROS and permeability transition pore opening [19].   
Autophagy can be classified as micro-autophagy, macro-autophagy and chaperone-
mediated autophagy. In micro-autophagy the lysosome itself directly take up the cargo. 
In chaperone-mediated autophagy the cargo makes a complex with a chaperone and this 
complex is recognized by the lysosomal membrane. In macro-autophagy an 
autophagosome delivers cargo to the lysosome and it will be referred as autophagy only 
[13].  
This process appears to randomly degrade cargo but there is evidence that the 
phagophore can recognize proteins in the target cargo. It acts as a receptor interacting 
with an adaptor promoting a selective degradation. Selective autophagy is significant for 
diseases and it seems to be correlated with normal growth conditions and not associated 
with disease while non-selective autophagy is associated with starvation.  
Autophagy plays a housekeeping role removing damaged organelles such as 
mitochondria. The oxidative phosphorylation occurs in mitochondria generating ATP by 
transfer electron to oxygen. The reactive oxygen species (ROS) production is inevitable 
in this metabolism and it can cause mitochondrial damage [20]. The removal of 
mitochondria results in a decrease of these species. The damage caused by ROS 
production can induce the opening of pores with high permeability leading to ATP 
depletion and promoting apoptosis [21]. So, mitophagy is a term used to refer to 
autophagy-dependent degradation of mitochondria and it is a mechanism of self-defense 
of the cell. It is relevant to limit ROS production and prevent the oxidation of 
biomolecules such as lipids and proteins. Starvation is also a mitophagy inducing factor 
[22]. It causes depolarization of mitochondria that move into vacuoles where they are 
subjected to acidic conditions. The membrane that surrounds and sequesters 
mitochondria after nutrient deprivation is LC3-containing [21]. Several molecules are 
implicated in yeast mitophagy, which are Uth1 a protein required to mitochondrial 
clearance and Atg32 that interacts with Atg8 and Atg11, all LC3 proteins, that act as a 
receptor, but there are no known homologues in mammals [23,24]. Although there is an 
amino acid motif required for the interaction that is conserved in p62. The existence of 
Parkin, an E3 ubiquitin ligase, in the mitochondria outer membrane and ability of the 
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UBA domain of p62 to bind to ubiquitin chains suggests that ubiquitinated molecules 
are required to promote selective autophagy [25]. 
2.1.1. Lipids in Autophagic Signaling  
Lipids and particularly phospholipids have been also considered key players in 
autophagy. Phosphoinositides (PI) and their derivatives of PIPS formed by 
phosphorylation/desphosphorylation of the inositol group, have important role in cell 
signaling and also in autophagy. Phosphatidylinositol-3-phosphate (PI3P) for example 
is required for autophagy [26]. It is localized in autophagic structures and promotes 
negative curvature and thus controls autophagosome (AP) size. It is also highly enriched 
on the inner surface of phagophores and coordinate specific effectors necessary for 
downstream transduction [27]. However, PI(3,4,5)P3 and class I phosphatidylinositol 3-
kinase (PI3K) have been shown to inhibit autophagy through activation of Akt pathway. 
Akt activates Rheb which in turn promotes mTOR that suppresses autophagy [28]. By 
contrast, in starvation, mTOR is inactivated and autophagy is positively regulated by 
PI(3,4,5)P3 phosphatase [29]. Class I PI3K, however, was recently shown to positively 
regulate autophagy by association with class III PI3K, independently of the Akt-TOR 
pathway, leading to increase in PI3P production [30]. So, different PI3Ks tightly 
regulate autophagy. 
Apart from being the main precursor for most phospholipids, the phosphatidic acid 
(PA) has also important signaling functions. Its cone-shape is thought to directly affect 
membrane dynamics inducing negatively curvature, facilitating the budding or fusion of 
vesicles [31]. PA has been shown to activate mTOR signaling and thus inhibit 
autophagy by direct interaction. It was reported that the PX domain containing 
phospholipase D1 (PLD1), which makes PA from PC, is part of an aminoacid-sensing 
mTOR pathway. PLD1 binds primarily to PI3P and PI(3,4,5)P3 on lysosomes thereby 
stimulating PLD1 activity. This binding occurs in lysosomes to ensure that PA is made 
in the proximity of mTOR [32]. On the contrary, it was reported that starvation induces 
PLD1 activity, increasing PA that activates mTOR and inhibits autophagy. It was also 
found that PLD1, under starvation, relocalize to autophagosome membrane suggesting 
that PA would be generated on autophagosomal membrane [33]. Additional 
investigations are required to find out if the role of PA is through its conversion in other 
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lipids, if it is required for membrane curvature or if PA recruits proteins involved in 
autophagy [26]. 
PA acts as mTOR activator and for that inhibits autophagy. But on the other hand, 
PLD1 produces PA and it is required for autophagy. These contradictory facts could be 
explained by a rapid turnover of PA to other lipids. Diacylglycerol (DAG) for example 
has been shown to induce autophagy [34]. DAG activates protein kinase C δ (PKCδ), 
which in turn activates c-Jun N-terminal kinase (JNK). JNK phosphorylates Beclin1 
inhibitor Bcl-2 to cause Bcl-2 dissociation resulting in activation of autophagy by the 
class III PI3K [35]. 
Ceramide (Cer) and Sphingosine-1-phosphate (S1P) that can be formed by 
hydrolysis of sphingomyelin both induce autophagy [36]. They inhibit mTOR but at 
distinct steps resulting in different outcomes. Ceramide induces cell death with 
autophagic features [37], while S1P induces autophagy that protects from cell death 
[38]. Ceramide acts upstream of S1P and triggers a stronger autophagic response not 
affected by starvation. It inhibits class I PI3K/Akt pathway causing Bcl2 to dissociate 
from Beclin1 by JNK [39]. Several autophagy genes are regulated by transcription 
factor FOXO3, which is inhibited by Akt. Ceramide relieves this inhibition promoting 
autophagy [40]. The role of ceramide could also be structural since it favors negatively 
membrane curvature [27]. Sphingosine kinase 1 (SK1) produces S1P which increases 
autophagy by inhibition of mTOR, independently of Akt [38]. The activity of SK1 
increases during starvation. This leads to starvation-induced autophagy. Depletion of 
sphingosine-1-phosphate phosphohydrolase (SPP1) was also shown to increase S1P 
levels and induce autophagy independently of mTOR [41]. 
   Cardiolipin (CL) is mainly found in the inner membrane of mitochondria being 
important not only for its normal function but also to apoptosis [42]. The BH3-only 
protein ApoL1 causes cell death by sequestering PA, which activates mTOR, and CL, 
which activates mitochondria-mediated apoptosis. This alters the balance between 
survival and death leading to autophagic cell death [43]. Apoptosis will be discussed 
later. The human immunity-related GTPase M (IRGM) is another CL-binding protein. 
IRGM affects mitochondrial fission to induce autophagy. It can either confer autophagic 
protection or cell death. It is known that knockdown of IRGM causes abnormal 
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elongation of mitochondria thus inhibiting autophagy [44]. However, a recent study 
reports that mitochondria are elongated in the course of starvation [45]. 
2.1.2. Lipid alteration related to autophagy 
Lipids are also targets for autophagic degradation, a process called lipophagy. 
Lipids are stored in the cell in the form of lipid droplets (LDs) that consist of cholesterol 
and triglycerides (TG) surrounded by a phospholipid monolayer. These lipids stored in 
LDs can be mobilized to generate energy when needed. In fact, LDs tend to be 
accumulated as a cause of disruption of autophagy. The degradation of LDs through 
lipophagy can also be stimulated by starvation. It is known that lipid metabolism is 
affected in the course of starvation but it is yet to know if lipophagy depends on a LD-
specific cargo receptor as in other selective autophagy processes [46]. A study using 
hepatocyte-specific Atg7-knockout mice revealed that high lipid loads seem to inhibit 
autophagy resulting in a further lipid accumulation. Since these mice have a very similar 
phenotype to that of human fatty liver disease, this negative feedback contributes to 
diet-induced fatty liver disease [47]. The accumulation of LDs is also associated with 
several other metabolic diseases including diabetes [48].  
LDs are the major site of cholesterol storage that in the form of cholesteryl esters are 
associated with atherosclerosis. Recent studies show that autophagy is activated upon 
exposure to oxidized LDL. This stimulates delivery of cholesterol to lysosomes where it 
is degraded thereby generating free cholesterol for efflux and transport to the liver. 
Autophagy is important in cholesterol efflux because Atg5 macrophages have a reduced 
ability to clear accumulated cholesterol [49]. 
In contrast to the liver, inhibition of autophagy in adipocytes prevents the 
accumulation of TG. Mice with adipocyte-specific knock-out of Atg7 have decreased 
white adipose tissue mass and a switch to production of brown adipocytes. The 
increased brown adipocytes prevent accumulation of lipids in other organs such as the 
heart. Thus, inhibition of autophagy in adipocytes may be beneficial. However, the dual 
role need more studied before autophagy can be targeted as a potential therapy for 
disorders such as atherosclerosis [50,51].  
  Apoptosis: a programmed cell death 
Apoptosis was first described in the twenty century as a mechanism of controlled 
cell deletion, which appears to be complementary but opposite to mitosis in the 
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regulation of cell population [52]. In current days we know apoptosis as the most 
meticulously form of programmed cell death. It is considered a central component of 
various processes including normal cell turnover, proper development and functioning 
of the immune system, hormone-dependent atrophy, embryonic development and 
chemical-induced cell death [16]. 
There are two major apoptotic signaling pathways: the intrinsic pathway and the 
extrinsic pathway. The main difference between them is the involvement of Bcl-2 
protein family that only regulates the intrinsic pathway. The Bcl-2 family have been 
gathered in three classes: the first inhibits apoptosis as Bcl-2, Bcl-x and Mcl-1; the 
second induces apoptosis as Bax and Bak; the third is BH3-protein as Bad and Bid, 
which enhances apoptosis by regulation the anti-apoptotic class relieving the inhibition 
of Bcl-2 leading to the promotion of apoptosis [53]. 
A wide variety of signals, including hypoxia, activate the intrinsic apoptotic 
pathway [16]. The signal starts to activate p53 which binds to DNA promoting the 
transcriptional upregulation of target genes, for instance apoptotic gene Bax. Bax 
oligomerization in the outer mitochondrial membrane (OMM) leads to mitochondrial 
outer membrane permeabilization (MOMP) and release of proteins from intermembrane 
space to the cytoplasm [54]. Several pro-apoptotic proteins are released such as AIF 
neutralizing inhibitors of apoptosis proteins (IAP). AIF translocate to the nucleus and 
causes DNA fragmentation and condensation of chromatin [55]. Another protein 
released is cytochrome c that is able to bind to apoptotic protease in the presence of 
ATP and activate factor-1 [53]. This process develops a complex named apoptosome 
which recruits procaspase 9 that after being activated to caspase 9 by cleavage of the 
prodomain recruits in turn the procaspase 3. Caspases (cysteine-utilizing aspartate-
cleaving proteases), as described by their designation, are proteases with cysteine in the 
active site. Caspase 3 activated is the straight responsible for cell death. It activates 
others proteins which produce the characteristic changes in an apoptotic cell. Some of 
these changes are plasma membrane blebbing, cell shrinkage, DNA fragmentation, 
chromatin condensation and apoptotic body formation [56]. 
The activation of the extrinsic apoptotic pathway is the responsibility of death 
ligands with no involvement of Bcl-2 family. The death ligands interact with the 
respective receptor and trigger a cascade of events. Fas ligand and TNF-α  are  the  death  
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ligands that interact with two different receptors on the plasma membrane. Although the 
ligand and the receptor are different, both recruit procaspase 8 that is autocatalytic 
activated. Caspase 8 in turn recruits procaspase 9 that is activated to caspase 9 which 
recruits procaspase 3. Caspase 3 activated produces the same results as in the intrinsic 
pathway resulting in characteristic changes in the apoptotic cell [56]. 
2.2.1. Apoptotic-induced Changes in Lipids 
The apoptotic machinery is based on proteins. Additionally, it has been suggested 
crucial functions for lipids in apoptosis and cooperation between lipid metabolism and 
BCL-2 proteins [57]. It is reported a membrane important role in propagation of the cell 
death response [58]. The two key cases are cardiolipin and sphingolipid metabolism. 
 Ceramide is the hub of sphingolipid metabolism. The major pathways of ceramide 
biosynthesis are de novo synthesis, sphingomyelin hydrolysis and sphingosine salvage 
[59]. In order to know how sphingolipid metabolism accommodates key factors in 
apoptosis, it is important to exam the enzymes surrounding ceramide metabolism. The 
three fundamental enzymes are sphingomyelinase (SMase), dihydroceramide synthase 
(CerS) and sphingosine kinase (SPK), highlighted in Scheme 3. 
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Scheme 3. Sphingolipid biosynthesis. Ceramide is generated via three major pathways 
including SM hydrolysis by sphingomyelinase (SMase). Ceramidase (CDase) degrade 
ceramide to sphingosine, which can be irreversibly degraded by sphingosine lyase to 
ethanolamine phosphate and hexadecenal, phosphorylated by sphingosine kinase (SPK) 
to sphingosine-1-phosphate (S1P) or acylated by dihydroceramide synthase (CerS) to 
regenerate ceramide. 
Bcl2 family-dependent apoptosis via endogenous SMase-mediated ceramide 
elevation has been observed in different cell types in response to diverse set of signals 
[57]. The antibiotic minocycline protected rat cortical neurons against bacterial 
sphingomyelinase (bSMase) by up-regulating BCL-2 expression [60]. Ceramide 
elevation and BAX translocation were also observed upon hypoxia/reoxygenation (H/R) 
of NT-2 human neuronal precursor cells [61]. Treatment of leukemia cells with the 
anticancer agent led to an increase in ceramide level where the first peak corresponded 
to SM hydrolysis and the second peak was attributable to CerS [62]. Mitochondria-
specific ceramide pool is necessary for mediating the TNFα apoptotic response in MCF-
7 cells [63]. SMase was also indispensable for UV-induced BAX conformational 
change at the mitochondria of several cell types. It was not observed any UV-induced 
BAX conformational change neither cyt c released in cells with SMase compromised 
activity [64]. 
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Ceramidases (CDases) degrade ceramide to sphingosine, which can be irreversibly 
degraded by sphingosine lyase to ethanolamine phosphate and hexadecenal. This is 
phosphorylated by sphingosine kinase (SPK) to sphingosine-1-phosphate (S1P) or 
acylated by dihydroceramide synthase (CerS) to regenerate ceramide. There are six 
mammalian CersSs. BCL-2 family-regulated apoptosis via endogenous CerS-mediated 
ceramide elevation has been observed in multiple cell types in response to a wide range 
of stimuli. A requirement for CerS in BCL-2 protein-dependent caspase activation was 
also observed [65]. Ceramide elevation preceded BAX activation, and inhibition of 
CerS led to reduced BAX insertion, oligomerization and cyt c release, implying UV-
induced ceramide synthesis is required for BAX-dependent apoptosis [66]. SPK has two 
known mammalian isoforms. SPK1 and 2 have opposing cellular functions. While 
SPK1 activation leads to pro-survival phenotypes, SPK2 enhances apoptosis in multiple 
cell types. Down-regulation of SPK2 lead to decreased sphingosine conversion to 
ceramide while down-regulation of SPK1 has the opposite effect. In endoplasmic 
reticulum (ER) SPK1 promoted apoptosis suggesting that S1P role depends on its 
localization [67]. 
Changes in the expression of BCL-2 proteins, particularly Bax, can alter apoptotic 
sensitivity by modulation of sphingolipid metabolism. BCL-2 overexpression inhibited 
SMase activity, ceramide production, cyt c release and caspase activation [68]. It was 
reported the assembly of ceramides into channels to facilitate protein release in the 
apoptotic program. Ceramide channels can interact with BCL-2 proteins demonstrating 
that ceramides and BAX acted synergistically to promote membrane permeabilization 
[69].  
Cardiolipin is found exclusively in mitochondrial membrane. CL exerts control over 
the mitochondrial apoptotic pathway primarily through the BH3 domain-only 
messenger BID. An intact BID is necessary for interaction with the BH1 domain of 
either BAX or BCL-2, and induced BID expression promoted apoptosis. BID was 
identified as caspase-8-dependent cyt c releasing factor. BID can be cleaved in response 
to Fas and TNF signaling. The resulting fragment cooperates with Bax to promote 
membrane permeabilization and cyt c release [70]. Among several roles, CL acts as a 
docking site for Bcl-2 proteins and caspase-8 [71]. Additionally, CL acts as an anchor 
for cytochrome c. Cyt c is anchored to the inner mitochondrial membrane (IMM) 
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between complex III and IV of respiration chain [72]. CL peroxidation allows cyt c 
release from IMM and may occur due to ROS, for example. The superoxide generation 
is an essential step towards cyt c release and depends on Bcl-2 proteins [73]. 
  Exosomes 
Exosomes are becoming popular since they have been recognized as important 
mediators in cell-cell signaling events. First it was though that extracellular vesicle (EV) 
bud directly from the plasma membrane but in the early 80s a study described a more 
complex mode of EV secretion. It was shown that small vesicles were formed inside an 
intracellular endosome, leading to multivesicular body (MVB) formation with 
subsequent fusion with the plasma membrane [74].  In  1987s  the  word  “exosomes”  was  
proposed for these EVs of endosomal origin. The term exosomes will be used as defined 
by Rose Johnstone and not the more general use for any vesicle released by cells [75].  
Secreted exosomes are biologically active entities that play specific biologic roles 
[76]. Exosomes are an alternative to lysosomal degradation of proteins that are resistant 
to degradation by lysosomal proteases since they are secreted to discard membrane 
proteins useless in the cell [14]. They play an immunological mediator role, for 
example, exosomes secreted by Eppstein-Barr virus (EBV)-transformed B cells 
stimulate human CD4+ T-cell clones in an antigen-specific manner [77]. Meanwhile, 
exosomes produced by dendritic cells (DC) have also an immunological role. After the 
pathogen uptake, immature and mature DC, generate MHC complexes and some of 
these complexes could be secreted on exosomes [78]. These exosomes sensitize others 
DC that have not encountered the pathogen directly, increasing the number of DC that 
bear the relevant MHC complexes and thereby amplify the magnitude of immune 
response [14,78]. Exosomes are capable of intercellular transport of functional DNA 
and RNA. The horizontal transference of genetic material between cells induces 
exogenous expression and mediates RNA silencing [14,76,79]. 
Proteomic studies revealed that exosomes contain a specific subset of proteins from 
endosomes, the plasma membrane and the cytosol [80]. Different cell origin results in 
different composition. So, exosomes do not contain a random set of protein but 
represent a specific subcellular compartment [80]. Although investigations of the lipid 
composition of exosomes were not as recurrent as proteomic analyses, the few studies 
published so far revealed that exosomes have differences in lipid composition when 
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compared to the cell membranes. Thus, the lipid profile of exosomes were studied and 
reported to be constituted mainly by glycosphingolipids, sphingomyelin, cholesterol, 
ceramide and phosphatidylserine [81]. Some of these lipids and proteins are enriched in 
lipid rafts and, indeed, there is a link between endocytosis of lipid rafts and secretion 
into exosomes [82,83]. 
The exosomes biogenesis process is divided into MVB formation mechanisms, 
transportation of MVB to the plasma membrane and fusion of these MVB with the 
membrane (Scheme 4). The intraluminal vesicles (ILV) are formed by inward budding 
from the limiting membrane. The molecular mechanism involved in biogenesis includes 
endosomal sorting complex required for transport (ESCRT) machinery, lipids and 
tetraspanin. It is not known if act simultaneously on the same or on different MVBs. 
The ESCRT consists of four complexes in which ESCRT-0 is responsible for cargo 
clustering, ESCRT-I and II induce bud formation and ESCRT-III drives vesicle 
scission. The VPS4 ATPase, an accessory protein, allows the dissociation and recycling 
of the ESCRT machinery [82]. Several studies have showed that cells with depletion of 
ESCRT key component still form MVBs, thus this suggests an ESCRT-independent 
mechanism [84]. Lipids are key players in the molecular mechanism to exosomes 
biogenesis. Ceramide was proposed to induce inward curvature of the limiting 
membrane of MVBs to form ILVs. Cholesterol is an important component of MVBs 
and it accumulation was shown to increase the secretion of vesicles. Phospholipase D2, 
enriched in exosomes, is involved in hydrolysis of phosphatidylcholine (PC) to 
phosphatidic acid (PA). PA, as described for ceramide, induces inward curvature and 
thus formation of ILV. Proteins are also involved in the molecular mechanism of 
exosomes biogenesis. Tetraspanins are four-transmembrane domain proteins enriched in 
ILVs of MVBs and exosomes, and are responsible for select cargos for exosome 
secretion. TSPAN8 is an example that modifies both the mRNA content and the protein 
composition of exosomes. The HSC70, a heat shock protein, allow the recruitment of 
the transferrin receptor (TFR) to exosomes [82].The RAB family of small GTPase 
protein controls different steps of intracellular vesicular trafficking such as vesicle 
budding and docking of vesicles to their target compartment ultimately leading to 
membrane fusion. These RAB proteins function is docking MVB to the plasma 
membrane, which is a required process for eventual fusion. After docking, soluble NSF-
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attachment protein receptor (SNARE) complexes are instrumental in allowing fusion of 
the lipid bilayers. However, SNAREs do not necessarily mediate the fusion of MVBs 
with the plasma membrane during exosome secretion [82].  
 
Scheme 4. Schematic representation of the machineries of exosomes biogenesis and 
secretion. 
During stress conditions, the cell tends to segregate exosomes in order to protect the 
cell from apoptosis. A high level of exosomes is detected in cardiovascular diseases 
which make them potential indicators for early diagnostics [85]. While protein 
modulation in exosomes under cellular stress is known, the role of phospholipids is still 
overlooked and deserves to be explored.  
2.3.1. Molecular Lipidomic of Exosomes 
The molecular lipid composition of exosomes is largely unknown. Recent studies 
have been shown lipid profile of exosomes released from some cells, for example 
prostate cancer cells [81]. In this study, it was quantified approximately 280 molecular 
lipid species. Exosomes showed enrichment in distinct lipids such as 
glycosphingolipids, sphingomyelin, cholesterol and phosphatidylserine. Additionally, 
this study also shows that cholesterol, long-chain sphingolipids, and PS 18:0/18:1 are 
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enriched to a similar extent in exosome membranes. The analysis of lipid species helps 
to understand the biogenesis of exosomes, their stability in the extracellular 
environment and/or the interaction of exosomes with other cells. Thereby, the high 
content in glycosphingolipids, for example, is related to exosome role in cell-to-cell 
communication since it confers exosomes with the stability needed for extracellular 
environments [86]. The great enrichment of specific glycosphingolipids such as HexCer 
and LacCer in exosomes suggests that these lipids could potentially be used as cancer 
biomarkers [81]. 
It has also been shown that exosomes from mast cells have the ability to induce 
phenotypic and functional maturation of DCs [87]. Since the mechanisms underlying 
these immunological properties are not clearly understood, the characterization of lipids 
present on exosomes could help to elucidate them. Exosomes released from DC have 
phospholipids and cholesterol as major components of the membrane. It was also 
showed an increase in SM content in exosome compared to the cell. Molecular species 
of the major phospholipids, PC and PE, were analyzed. The results showed an increase 
in saturated species. The high content of SM and the di-saturated molecular species are 
known to affect lipid packing in membranes. In terms of cholesterol, it was identical 
with that of presented in cells [88]. It has also been observed in this study that the 
proportion of LPC is relatively high in exosomes. The presence of LPC might be 
essential for the activity in vivo, since LPC trigger DC maturation [89]. 
2.3.2. Exosome as an Agent in Cardiac Repair 
It is known that myocardial infarction is a leading cause of death. Even though there 
are some therapeutically approaches to cardiac damage, there is a need for novel 
treatments to reduce subsequent cardiac remodeling that can adversely affect heart 
function. How the myocardium initiates the local repair process post-MI or how it 
manipulates the bone marrow (BM) environment to induce stem cell mobilization are 
question yet to respond. The exosomes seems to come as a possible response to the 
questions above [85]. 
A major component of the healing response is scar formation, rather than muscle 
regeneration. This is due to the limited ability of the heart to rapidly response [90]. 
However, the limited endogenous reparative mechanisms seem to depend more on the 
replenishment by progenitor cells than on replacement by cardiomyocytes proliferation 
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[91]. It was suggested that the release of stem and progenitor cells by BM could help in 
the turnover of vascular endothelium and myocardial repair response after MI [92]. MI 
induces rapid mobilization of BM-derived stem cells (BM-SCs). These are related to 
reparatory response and it was already reported an important role of BM-SCs in cardiac 
repair [92]. In MI, the levels of soluble inflammatory mediators, cytokines, and growth 
factors are significantly increased. They are release by ischemic tissue to mobilize BM-
SCs to them. So, these molecules act as chemoattractants [92]. The complete 
mechanism of BM-SC mobilization is much more complicated because other signaling 
pathways and mechanisms, including exosomes and miRNAs, could promote trafficking 
and engraftment of BM and cardiac SCs. 
Cardiomyocytes are generally not considered a typical secretory cell but in addition 
to several factors can release exosomes. This exosomes may provide the underlying 
mechanisms by which the damaged heart communicates with other tissues to initiate the 
repair process, and how stem/progenitor cells repair and regenerate the myocardium 
[93]. Once secreted, exosomes either interact with surrounding cells or can be released 
to the systemic circulation [94]. Exosomes from a specific cell of origin can selectively 
bind and be internalized by certain target cell types. However, the cellular and 
molecular basis for this targeting is still undetermined. After endocytosis, exosomes can 
fuse with the endosomal membrane or can be targeted to lysosomes for degradation. 
They mediate communication through transfer of proteins, mRNA, miRNA [95]. 
It is suitable to propose that exosomes can be important communicators of ischemic 
signaling and myocardial repair. Few reports have suggested that cardiomyocytes 
secrete exosomes under healthy and ischemic conditions and that they are involved in 
communication in the heart [96]. For the first time, it was provided evidence that 
exosomes are secreted by progenitor cells. Moreover, it was also shown that 
cardiomyocytes are able to uptake exosomes [96]. An in vivo study [85] suggested that 
exosome secretion from the cardiomyocytes was significantly increased under hypoxic 
stress. Exosomes are known to target via the transfer of proteins or genetic materials 
such as mRNA and miRNAs. This suggests that exosomes generated by cardiomyocytes 
are able to transfer proteins and genetic material to other cells. However, it is not clear 
whether exosomes have any physiological function for example, in heart remodeling 
and repair [85]. 
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Recent studies demonstrate that cardiac and circulating miRNAs are markedly 
altered after MI [97]. The muscle-specific miR-1 and miR-133, for example, are 
increased in the serum of patients with acute coronary syndrome. These miRNA levels 
correlate with serum cardiac troponin T levels. They have shown that the origin of this 
miRNA is the infarct zone and that this miRNA released in exosomes from H9C2 cells 
[98]. Additionally, a cardioprotective miR-214 has been shown to be upregulated in the 
heart after ischemia and to be secreted via exosomes from human endothelial cells [99]. 
As these miRNAs are released even before the release of cardiac troponin T, these could 
function as biomarkers for the early detection of acute MI [85]. Interestingly, several 
reports suggest circulating miR-126 to be an important miRNA to indicate the damage 
and repair mechanisms in acute MI patients [100]. Circulating human CD34+ stem cell–
derived exosomes are enriched with miR-126 [101]. The miR-126 is reported to induce 
the expression of CXCL12, promoting the recruitment of progenitor cells by a feedback 
mechanism [102]. Further experimental studies are necessary to explore the mechanism 
behind of which MI affect circulating exosomal miRNA levels. 
Recent study proposed a novel mechanism by which circulating exosomes from a 
tumor could crosstalk, reprogram, and permanently educate the BM progenitor cell to 
mobilize out of the BM [103]. This shows the complexity of the cargo carried by 
exosomes and its enormous potential to directly influence the biology of distant 
microenvironments. Although this work relies on cancer, it has obvious potential 
implications in cardiology. Several recent reports demonstrate that acute MI modulates 
the miRNA expression of BM cells both in humans and in mice [104]. Other reports 
suggest that cardiac ischemia mobilizes BM mononuclear cells via downregulating the 
expression of miR-150 activating CXCR4 in BM mononuclear cells [105]. Collectively, 
this evidence strongly supports that cardiac exosomes released after ischemic insults 
affect the BM microenvironment to reprogram the BM cells and initiate a repair process 
[89]. 
Exosomes are vesicles recognized as an important intercellular system of 
communication between cells and tissues. The biological role of exosomes seems to be 
dependent not only on the protein and RNA content, but also on the bioactive lipid 
content. They have been reported in all biological fluids and can be associated with 
specific pathophysiological situations [106]. Thus, it is important to recognized lipid 
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profile of exosomes and it variations depending on the environmental and 
pathophysiological conditions. 
 Lipid profile and Lipid Oxidation in Cardiovascular Diseases 
Lipids are a group of biomolecules that embraces a diversity of molecules with 
different structural features and different functions. The International Lipid 
Classification and Nomenclature Committee describes   lipids   as   “hydrophobic   or 
amphipathic small molecules that may originate entirely or in part by carbanion based 
condensation of thioester (fatty acyls, glycerolipids, glycerophospholipids, 
sphingolipids, saccharolipids, and polyketides) and/or by carbocation-based 
condensations of isoprene   units   (prenol   lipids   and   sterol   lipids)”.  These eight lipid 
categories are further subdivided on the basis of chemical structures (Figure 3) [107]. 
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Figure 3.  Lipid categories according to the LIPID MAPS lipid-classification system. 
Lipids, namely phospholipids (PL), are the major component of a cell membrane. In 
addition to that structural function, lipids play multiple crucial roles within cells, such as 
energy storage and as substrates for the synthesis of signaling mediators. Several studies 
reported an importance of a specific lipid environment to a proper function of 
membrane protein [108]. Different types of assemblies have been described for the 
interaction of membrane proteins with lipids. Although some proteins depend on being 
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surrounded by a specific lipid shell, some multimeric proteins specifically bind 
individual lipids that are important for the structure of these protein complexes [109]. 
Recent studies suggest that lipids can also act as protein co-factors modulating their 
activity [110].  
However under several physiopathological conditions, lipids can be modified by 
reactive oxygen species (ROS) that are generated from life processes and can cause 
disturbance of pro and antioxidant systems. This oxidative stress is responsible for basic 
oxidation reaction mechanisms. Lipids are primary targets of ROS attack [111]. Lipid 
peroxidation leads to the formation of a variety of oxidized products mainly due to the 
modifications of polyunsaturated fatty acyl chains. When the oxidation is nonenzymatic 
it is expected as the result several new products with new bioactivities, some deleterious 
to cells and tissues. On the contrary, when the oxidation is enzymatic it is a highly 
regulated physiological event involving receptors and intracellular signaling. These 
oxidized products are generated by proteins such as lipoxygenases (LOX) and 
cyclooxygenases (COX) existing in all mammalian species. In this case lipids have a 
role in immunity and homeostasis [112]. 
Oxidative stress, which is associated with lipid peroxidation, is a key factor in 
atherosclerosis. Oxidized phospholipids (OxPL) play a significant role in atherosclerosis 
[113]. An important marker of oxidative stress is the association of oxidized 
phospholipids with the apolipoprotein B-100. Increased levels of OxPL/apoB are 
implicated in coronary artery disease, progression of atherosclerosis and prediction of 
new cardiovascular events [114]. Other studies have demonstrated increased levels of 
auto-antibodies against oxPL in patients with hypertension and myocardial infarction 
[115]. Thus, oxPL could be used as a biomarker for cardiovascular diseases. 
Biologically active oxidized phospholipids can initiate and modulate many cellular 
events. In aortic endothelial cells, OxPL modulate the expression of a variety of genes 
related to angiogenesis, atherosclerosis and inflammation [116]. Additionally, oxPL can 
activate platelets, inducing differentiation of monocytes and de-differentiation of 
smooth muscle cells. These are all processes related to atherosclerotic plaque formation.  
They also can modulate the fate of an inflammatory response by intervening in the 
processes by removing apoptotic cells [117]. Nowadays it is recognized the importance 
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of oxidized lipids as a key players in the onset of cardiovascular diseases and oxidized 
lipids have been considered as possible biomarkers for cardiovascular disease [115]. 
 Lipidomic Approach in Diagnosis of Cardiovascular Diseases 
Lipidomic is the analysis of molecular lipid species, including their quantitation and 
metabolic pathways [118]. It may be used to risk assessment and therapeutic monitoring 
due to the diversity of roles that lipids play in distinct cellular functions. Lipid 
imbalance or dysregulation result in consequences for multiple biological functions, 
culminating in the development of disease. Since lipids are involved in the 
pathophysiology of several diseases, lipidomics has the potential to improve prediction 
of future disease risk, inform on mechanisms of disease pathogenesis, identify patient 
groups responsive to particular therapies and more closely monitor response to therapy 
[119]. Lipidomic came as an alternative to genetic, epigenetic and gene expression 
measures which are further upstream in disease aetiology. The method of choice for 
identification of lipidomic biomarkers is mass spectrometry, either by direct infusion or 
coupled with liquid chromatography [118]. In what concern cardiovascular disease, the 
majority of studies reported alteration in lipids from plasma as toll for the identification 
of biomarkers of CVD [120]. Plasma lipidomics provide a detailed picture of the 
dysregulation of lipid metabolism. It has been used to identify lipidomic biomarkers 
associated with a variety of diseases including type 2 diabetes and cardiovascular 
diseases [120]. However the work concerning lipid changes in cardiomyocytes and 
exosomes released by them are absent.  
Dysfunctional lipid metabolism is associated with atherosclerotic cardiovascular 
diseases. The stability of atherosclerotic plaque is important since its disruption is an 
important cause of vascular events. Lipids may act to promote plaque instability and 
rupture and whether plasma lipid analysis may provide insight into this process [119]. A 
plaque at risk of rupture has a marked abundance of both extra- and intra-cellular lipid, 
mainly cholesterol either esterified (CE) or unesterified (UC). The phospholipid content 
is similar to stable plaques and include essentially PC, PI, LPC and SM. The total 
classes of lipids observed are quite different as it were observed in unstable plaques 
approximately half of the classes observed in stable plaques [121]. 
Most of the published works are concerned with finding new plasmatic biomarkers 
associated with cardiovascular disease. However there are few who report changes at 
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the cellular level, including cardiomyocytes, and there are no studies on the lipid 
signaling carried by exosomes.  
 Aims 
Phospholipids and phospholipid oxidation products have been considered important 
players in cardiovascular diseases that are associated with ischemia, which occurs in 
consequence of hypoxia and deprivation of nutrient to the cardiomyocytes. However, 
there is a lack of knowledge on complete picture of the physiopathological process that 
underlies ischemia and also how recovery occurs, by selected processes such as 
autophagy. Since lipids, and particularly phospholipids, are important components of 
cells membranes involved in cell death and survival and as signaling molecules, it is 
important to understand lipid profile alterations in cell during starvation and hypoxia. 
The possible role of phospholipids in cardiomyocytes under these conditions 
encouraged us to explore and thus the major aims of this work will be:  
a) to identify the change in lipid profile of a myoblast cell line H9c2 under 
starvation and under ischemic conditions;  
b) to identify the changes in lipid profile of exosomes, released by myoblast 
cell line H9c2, under starvation and under ischemic conditions. 
Mass spectrometry based approaches are becoming increasingly important in lipid 
research allowing us to assess the changes on phospholipids caused by stress or 
pathological conditions. It will be used a lipidomic approach to identify the above 
reported variation in lipid profiling. The results that will be achieved intend to clarify 
the mechanism of modulation of lipid profile during starvation and ischemia and to 
evaluate the cell fate under such conditions. This will allow us to recognize new lipid 
biomarkers for ischemia and starvation associated with disease such as myocardium 
infraction. 
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  Chemicals 
Phospholipid internal standards (1',3'-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-sn-
glycerol (CL), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (dMPC), 1-nonadecanoyl-
2-hydroxy-sn-glycero-3-phosphocholine (LPC), 1,2-dimyristoyl-sn-glycero-3-
phosphoethanolamine (dMPE), 1,2-dimyristoyl-sn-glycero-3-phosphate (dMPA), 1,2-
dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (dMPG), 1,2-dimyristoyl-sn-
glycero-3-phospho-L-serine (dMPS) and 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-
myo-inositol) (dPPI)) were purchased to Avanti polar lipids, Inc (Alabaster, AL, USA). 
Primuline were purchased from Sigma (St Louis, MO, USA), triethylamine and 
potassium hydroxide were purchased from Merck (Darmstadt, Germany) and perchloric 
acid from Panreac (Barcelona, Spain). Acetonitrile; chloroform, methanol and hexane 
from Fisher Scientific (Leicestershire, UK) were of HPLC grade and were used without 
further purification. All other reagents and chemicals used were of highest grade of 
purity commercially available. Mili-QH2O used was filtered through a 0.22-mm filter 
and obtained using a Milli-Q Millipore system (Milli-Q plus 185). 
 Cell Culture 
The myoblast cell line H9c2 (Sigma-Aldrich, St. Louis, MO) were cultured in 
Dulbecco’s   Modified   Eagle   Medium   (DMEM)   (Life   Technologies,   Carlsbad,   CA),  
supplemented with 10% FBS, 1% Penicillin/Streptomycin (100 U/mL:100 μg/mL) and 
1% GlutaMAX (Life Technologies, Carlsbad, CA), at 37ºC under 5% CO2. Metabolic 
ischemia was induced by a buffer exchange to an ischemia-mimetic solution (in mM: 
118 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.2 CaCl2, 25 NaHCO3, 5 calcium 
lactate, 20 2-deoxy-D-glucose, 20 Na-HEPES, pH 6.6) and by placing the dishes in 
hypoxic pouches (GasPakTM EZ, BD Biosciences), equilibrated with 95% N2/5% 
CO2. Cells were stimulated with, unless otherwise stated, 2.5 μg/mL of exosomes in 
exosome-depleted medium, for the indicated time periods. Starvation was induced by 
growing cells during 24 hours in a complete medium without serum. 
 Exosomes Extraction 
The exosomes extraction was performed using an adaptation of two experimental 
protocols [122,123]. Serum was depleted of exosomes by ultracentrifugation at 154.000 
g, for 16 hours, in a 1:1 dilution to minimize serum proteins loss due to its viscosity. 
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Exosomes derived from cultured cells were isolated from conditioned medium after 
culture in either exosome-depleted medium or ischemia-mimetic solution, for x hours. 
Afterwards, the medium was collected and exosomes were isolated by 
ultracentrifugation64. In brief, the supernatants were subjected to differential 
centrifugation at 4°C, starting with a 300 g centrifugation, for 10 min followed by a 
16.500 g centrifugation for 20 min. To remove cellular debris and larger particles, the 
supernatants were filtered with a 0.22 μm filter unit, and then ultracentrifuged at 
120.000 g, for 70 min. The resultant pellet was washed with phosphate buffered saline 
(PBS) (1.5 mM KH2PO4, 155 mM NaCl and 2.7 mM Na2HPO4.7H2O pH 7.4) and, 
after a second ultracentrifugation, exosomes were ressuspended in PBS (sterile when 
used for biological assays). 
 Lipid Extraction 
The pellet of cells was re-suspended in 1 mL of Ultra-pure water (Mili-QH2O). 
Thereafter, total lipids were extracted using the Bligh and Dyer method [124]. Briefly, 
3.75 mL of a mixture of chloroform/methanol 1:2 (v/v) was added to the cell 
homogenate, vortexed very well and incubated on ice for 30 min. An additional volume 
of 1.25 mL chloroform was added followed by vortex. Then, 1.25 mL mili-QH2O were 
added also followed by strong vortex. The samples were centrifuged at 2000 rpm for 5 
min at room temperature to obtain a two-phase system: an aqueous top phase and an 
organic bottom phase. The lipid extract was recovered from the organic phase (bottom 
phase). In order to guarantee full extraction of lipid phase, 1.88 mL of chloroform were 
added to the aqueous phase followed by vortex and new centrifugation. The organic 
phase was recovered to the same tube as before and dried in the speedvac (UNIVAPO 
100H, Reagente5 – Química e Electrónica Lda.). After drying, the total lipid extracts 
were re-suspended in 300 µL of chloroform, transferred to a smaller tube, dried under 
nitrogen stream and stored at -20ºC. Three or different cultures were extracted and 
analyzed in order to verify the reproducibility of the results. 
 Quantification of Phospholipids 
In order to determine the PL amount in each extract, the phosphorus measurement 
was performed according to Bartlett and Lewi [125]. Briefly, 125 µL of percloric acid 
(70%) was added to standards and samples. Samples were incubated for 1h at 170°C in 
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a heating block (Stuart, U.K.), followed by cooling to room temperature. Phosphate 
standards from 0.1 to 2 µg of phosphorous (P) were prepared from a phosphate standard 
solution of dihydrogenphosphate dihydrated (NaH2PO4.2H2O) with 100 µg/mL of P. 
Thereafter, 825 µL of MilliQ water, 125 µL of ammonium molybdate (2.5 g ammonium 
molybdate/ 100 mL MilliQ water) and 125 µL of ascorbic acid (10 g ascorbic acid/ 100 
mL MilliQ water) were added to samples and standards, vortexed well following the 
addition of each solution and incubated for 10 min at 100°C in a water bath. After cool 
in a cold water bath, the standards and samples absorbance were measured at 797 nm in 
a microplate reader (Multiscan 90, ThermoScientific). These experiments were 
performed at least in triplicate, from different cell culture extracts (at least n=3 
independent experiments). 
  Thin-Layer Chromatography (TLC) 
Separation of several PLs classes from the total lipid extracts was achieved by TLC. 
Prior to separation, TLC plates (silica gel 60 with concentration zone 2.5x20cm ) were 
washed in a methanol: chloroform mixture (1:1, v/v) and left in the safety hood for 15 
min, then plates were sprayed with 2.3% (m/v) boric acid and dried in an oven at 100ºC 
during 15 min. Then 30 µg of total lipid extract dissolved in chloroform was applied on 
the TLC plates. The plates were dried with a nitrogen flow and developed with a 
mixture chloroform/ethanol/water/triethylamine (30:35:7:35, v/v/v/v). Lipid spots on 
the silica plate were observed and identified by spraying the plate with 50µg/100mL 
primuline solution dissolved in a mixture of acetone and mili-QH2O (acetone:water; 
80:20(v/v)), and visualized with a UV lamp (λ=254nm). Identification of PL classes was 
carried out with the use of phospholipid standards (SM, PC, PI, PS, PE, and CL), which 
run side by side in the TLC plate. Following separation the spots were scraped from 
TLC plates and used for quantification by phosphorus assay as previously described. 
 High Performance Liquid Chromatography Mass Spectrometry (HPLC-MS) 
HPLC-MS was performed with an internal standard to confirm and quantify the ions 
variations observed in the spectra. The PL standards used were PC (14:0/14:0), LPC 
(19:0), PI (16:0/16:0), PE (14:0/14:0), PA (14:0/14:0), PG (14:0/14:0), PS (14:0/14:0), 
SM (17:0/d18:1) and CL (14:0/14:0/14:0/14:0). PL classes were separated by HPLC–
MS, performed on an HPLC system (Waters Alliance 2690) coupled to an electrospray 
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linear ion trap mass spectrometer LXQ (ThermoFisher, San Jose, CA, USA). The 
mobile phase A consisted of 10% water and 55% acetonitrile with 35% (v/v) methanol. 
The mobile phase B consisted of acetonitrile 60%, methanol 40% with 10mM 
ammonium acetate. Total lipid extract were diluted in the mobile phase B (90 µL) and 
10 µL of reaction mixture was introduced into an Ascentis Si HPLC Pore column (15 
cm×1.0 mm, 3 μm) (Sigma-Aldrich). The solvent gradient was programmed as follows: 
gradient started with 0% of A and 100% of B. It linearly increased to 60% of A and 
decreased to 40% of B during 15 min, and held isocratically for 22 min, returning, to the 
initial conditions in 3 min. The flow rate through the column was 60 μL/min and it was 
redirected to a LXQ linear ion trap mass spectrometer (ThermoFinningan, San Jose, 
CA, USA) by a capillary (0.350 × 0.150 mm) of 70 cm length using a home-made 
split. The LXQ linear ion trap mass spectrometer was operated in negative-ion mode. 
Typical ESI conditions were as follows: electrospray voltage, - 4.7 kV; capillary 
temperature, 275 ºC; and the sheath gas flow of 8 U. To obtain the product-ion  spectra  
of  the  major  components  during LC experiments, cycles  consisting  of  one  full  
scan  mass  spectrum and  three  data-dependent  MS/MS  scans  were  repeated  
continuously throughout  the  experiments with  the  following  dynamic  exclusion 
settings:  repeat  count  3;  repeat  duration  15  s;  exclusion  duration 45 s. Data 
acquisition was carried out on an Xcalibur data system (V2.0). Relative quantification 
of each individual phospholipid specie was obtained by the ratio between the area of 
reconstructed ion chromatogram of a given m/z value against the area of the 
reconstructed ion chromatogram of the respective standard. At least three independent 
samples were analyzed. 
  Gas Chromatography Mass Spectrometry (GC-MS) 
Fatty acid methyl esters (FAMEs) were obtained after transesterification of lipid 
extracts according to the method described by Aued-Pimentel et al. [126]. Briefly, dried 
lipid extracts (30   μg   of   total   phospholipid) were dissolved in 1 mL n-hexane. A 
methanolic KOH solution (2 M) was added (200   μL), followed by intense vortex-
mixing for 1-2 min. Saturated NaCl solution (2 mL) was added. After centrifugation at 
2000 rpm for 5 min, the organic phase was collected and dried under a nitrogen stream. 
The resulting FAMEs were dissolved in n-hexane and volumes  of  2.0  μL were analyzed 
by gas chromatography–mass spectrometry (GC–MS) on an Agilent Technologies 6890 
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N Network (Santa Clara, CA) equipped with a DB-FFAP column with 30 m of length, 
0.32 mm  of  internal  diameter,  and  0.25  μm  of  film  thickness  (J&W  Scientific,  Folsom, 
CA). The GC equipment was connected to an Agilent 5973 Network Mass Selective 
Detector operating with an electron impact mode at 70 eV and scanning the range m/z 
50–550 in a 1 s cycle in a full scan mode acquisition. The oven temperature was 
programmed from an initial temperature of 80 °C, a linear increase to 160 °C at 25 °C 
min−1, followed by linear increase at 2 °C min−1 to 210 °C, then at 30 °C min−1 to 250 
°C and stays here for 10 min. The injector and detector temperatures were 220 and 280 
°C, respectively. Helium was used as carrier gas at a flow rate of 0.5 mL min−1. The 
relative amounts of FAs were calculated by the percent area method with proper 
normalization considering the sum of all areas of the identified FAs. 
  Statistics 
The results are presented as mean values and their standard deviations (mean ± SD) for 
each experimental group. Two-way analysis of variance (ANOVA) was used with the 
Bonferroni pos-test to evaluate significant differences among samples. A value of 
p<0.05 were considered to be statistically significant. Statistical analysis were 
performed using GraphPad Prism 5 software.  
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 Unraveling the modifications of myoblast cell line H9c2 lipidome towards 
starvation and ischemia  
In this work the changes in the phospholipid (PL) profile of myoblast cells cultured 
with deprivation of nutrients (starvation) and in conditions mimicking ischemia were 
evaluated, as physiopathological conditions associated with myocardium infarction. 
Comparison with control group allowed us to observe changes in the phospholipid 
profile that can be important to unravel cardiac cells death or recovery. 
In order to evaluate the alterations in PL profile, total lipid extracts were fractionated 
by thin layer chromatography (TLC) and each PL class was identified by comparison 
with PL standards applied into the TLC plate. The relative amount of each PL class was 
determined by phosphorous quantification of each spot attribute to each PL class and 
results obtained are shown in Figure 4.  
 
Figure 4. Thin-layer chromatography of total lipid extract obtained from untreated 
myoblast cells (control) and ischemic and starved cells. A- TLC plaque with the 
signalized spots for each PL class. Phospholipid standards were also applied: (PC) - 
Phosphatidylcholine; (PS) - Phosphatidylserine; (PE) - Phosphatidylethanolamine; 
(SM)- Sphingomyelin; (PG) - Phosphatidylglycerol; (PI)-phosphatidylinositol; (CL) - 
Cardiolipin. B-Relative phospholipid content of myoblast cells (control) and for 
ischemic and starved cells. The phospholipid classes were separated by thin-layer 
chromatography and the phosphorous content of each spot was calculated taking in 
account the amount of phosphorous in the total lipid extract. Phospholipid classes were 
separated and quantified. 
The most abundant class in all conditions was phosphatidylcholines (PC) followed 
by phosphatidylethanolamines (PE), phosphatidylserines (PS), sphingomyelins (SM) 
and cardiolipins (CL) and phosphatidylinositols (PI). We have identified significant 
alterations in the relative amount of PC and PS classes. It was observed a decrease in 
PC content in starved cells and a decrease of PS in ischemic cells, in comparison with 
control group. 
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The identification of the fatty acid proﬁle of the total lipid extract in all conditions 
and the quantification of the relative content of fatty acid composition were performed 
by GC–MS analysis of fatty acid methyl esters. In the total lipid extracts, the major fatty 
acids identified were: C14:0, C16:0, C16:1n-9, C18:0, C18:1n-9, C18:2n-6, C20:3n-9, 
C20:3n-6 and C20:4n-6 (Figure 5). An increase in the fatty acid C16:0 and C18:0 and a 
decrease in the fatty acid C18:1 was observed in ischemia while a decrease in fatty acid 
C20:4 was observed in starvation. 
 
Figure 5. Fatty acid profile of untreated myoblast cells (control) and associated with 
ischemia and starvation. 
Specific molecular composition of each PL class and information about the 
alterations in their profile at molecular level were achieved by using HILIC-LC-MS and 
MS/MS lipidomic approaches. In the LC-MS run we were able to identify all the six PL 
classes previously identified after TLC analysis but also two more PL classes: 
phosphatidylglycerols (PGs) and lysophosphatidylcholines (LPCs) (Table A.1). To 
ensure the reproducibility of the results, data were obtained, at least in triplicate, from 
different cell culture passages (at least n = 3). 
PC were identified as [M+CH3COO]- in LC-MS spectra and  in all conditions the 
most abundant PC molecular specie identified was PC (34:1) at m/z 818.3, followed by 
PC molecular species including PC (32:1), PC (34:2), PC (36:2) and PC (36:1) (Figure 
S.1). Significant alterations in PC molecular profile were observed after comparing 
starvation and ischemia conditions with the control group and also between each other 
(Figure 6). A statistically significant increase of PC(34:1) and  a decrease in PC(36:2) 
were observed for ischemia in comparison with control while a higher decrease of 
PC(34:1) was observed in starvation. Interestingly dissimilar deviations were observed 
for PC molecular specie PC(34:1) when the effect of  ischemia and starvation are 
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compared. In fact, PC(34:1) decrease in ischemia and increase in starvation. Also the 
decrease in PC(36:2) was observed exclusively for ischemia. 
 
Figure 6. Phosphatidylcholine (PC) molecular species content of untreated myoblast 
cells (control) and associated with ischemia and starvation analyzed by HPLC-MS in 
negative mode. Identification of PC molecular species with the indication of the C:N 
(carbon:unsaturation). 
In the LC-MS spectra of all conditions, five LPC molecular species, identified by 
their [M+CH3COO] – ions, were observed. In all conditions, the most abundant LPC 
molecular specie was LPC(18:0) at m/z 582.1, followed by LPC (16:1), LPC(16:0), 
LPC(18:1), LPC(18:2) and an alkylacyl LPC molecular specie (LPC(O-18:0)) (Figure 
S.2).  Comparison of LPC profile between all conditions with control allowed us to 
identify a significant increase in LPC(18:0) and a decrease in the LPC(18:1) molecular 
species for ischemia and for starvation. LPC(16:0) only decrease in ischemia (Figure 7). 
No differences were observed in LPC profile between starvation and ischemia. 
 
Figure 7. Lysophosphatidylcholine (LPC) molecular species content of untreated 
myoblast cells (control) and associated with ischemia and starvation analyzed by 
HPLC-MS in negative mode. Identification of LPC molecular species with the 
indication of the C:N (carbon:unsaturation). 
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The molecular species of SM were also identified in negative mode as 
[M+CH3COO]– ions. The ion at m/z 761.2 corresponding to SM(34:1) is the major 
molecular specie identified in all conditions (Figure S.3). For starvation, a significant 
decrease in the SM(34:1) was observed in comparison with control and ischemic cells 
(Figure 8). 
 
Figure 8. Sphingomyelin (SM) molecular species content of untreated myoblast cells 
(control) and associated with ischemia and starvation analyzed by HPLC-MS in 
negative mode. Identification of SM molecular species with the indication of the C:N 
(carbon:unsaturation). 
The molecular species of PE were analyzed in negative mode and identified as [M-
H]– ions. The molecular specie at m/z 716.2 (PE(34:1)) was the most abundant 
molecular specie identified in all conditions (Figure S.4). We observed an increase of 
PE(34:1) for ischemia and starvation in comparison with control (Figure 9). 
 
Figure 9. Phosphatidylethanolamine (PE) molecular species content of untreated 
myoblast cells (control) and associated with ischemia and starvation analyzed by 
HPLC-MS in negative mode. Identification of PE molecular species with the indication 
of the C:N (carbon:unsaturation). 
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PS was identified in negative mode as [M-H] – ions. The most abundant PS in both 
conditions was PS(36:1) at m/z 788.4 (Figure S.5). An increase in the levels of PS(36:1) 
were found for starvation in comparison with control and with ischemia (Figure 10). 
 
 
Figure 10. Phosphatidylserine (PS) molecular species content of untreated myoblast 
cells (control) and associated with ischemia and starvation analyzed by HPLC-MS in 
negative mode. Identification of PS molecular species with the indication of the C:N 
(carbon:unsaturation). 
The PI molecular species were identified as [M-H]– ions and the major PI molecular 
specie were PI(38:4) at m/z 885.4 and PI(38:3) at m/z 887.4 (Figure S.6). A significant 
increase of PI (38:3) and a decrease of PI(38:5) were observed for ischemia and 
starvation in comparison with control. An increase of PI(36:2) was observed  for starved 
cells when compared with ischemic (Figure 11). 
 
Figure 11. Phosphatidylinositol (PI) molecular species content of untreated myoblast 
cells (control) and associated with ischemia and starvation analyzed by HPLC-MS in 
negative mode. Identification of PI molecular species with the indication of the C:N 
(carbon:unsaturation). 
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PGs were also analyzed in negative mode as [M-H]– ions. Analysis of the MS and 
MS/MS spectra allowed us to identified several PGs molecular species being the most 
abundant the PG(36:2) at m/z 773.4 followed by PG(34:1) at m/z 747.4 and PG(36:1) at 
m/z 775.4 (Figure S.7). No significant alterations in PG molecular species were 
observed between conditions (Figure 12). 
 
Figure 12. Phosphatidylglycerol (PG) molecular species content of untreated myoblast 
cells (control) and associated with ischemia and starvation analyzed by HPLC-MS in 
negative mode. Identification of PG molecular species with the indication of the C:N 
(carbon:unsaturation). 
Overall the same PL molecular species were found for each PL class in control and 
either in ischemia and starvation. Interestingly, significant differences in the relative 
amount of specific molecular species were establish for all PL classes - except for PE 
and PG - between control and ischemia or starvation, as is summarized in Table 1. 
Some deviations were common to starvation and ischemia, while others seems to be 
correlated exclusively to starvation or ischemia.  
Table 1. Resume of the alterations observed in the molecular species of PC, LPC, SM, 
PE, PS and PI comparing control with ischemia, control with starvation and starvation 
with ischemia. 
Class Molecular species Control vS Ischemia Control vS Starvation Starvation vS Ischemia 
PC 34:1    36:2    
LPC 
16:0    
18:1    
18:0    SM 34:1    PE 34:1    
PS 36:1    
PI 
36:2    
38:5    
38:3    
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 New insights on the lipidome of the exosomes released by myoblast cell line 
H9c2 upon ischemia and starvation 
 
Identification of the phospholipid (PL) profile of exosomes released by myoblast 
cells was identified and the deviation in lipidome towards starvation and ischemia were 
also evaluated. Comparing conditions with control and between each other allowed us 
to observe changes in the phospholipid profile that can be important to unravel the role 
of exosomes in death or recovery. 
A lipidomic analysis was performed based on the results gathered by the HILIC-LC-
MS and LC-MS-MS to identify the specific molecular composition of each PL class and 
evaluate alterations in their profile at a molecular level. Due to the lower amount of 
lipid samples it was not possible to perform TLC or fatty acid analysis by GC-MS in 
these samples.  Analsyis of  LC-MS data allowed us to identify nine PL classes: 
phosphatidylcholines (PCs), lysophosphatidylcholines (LPCs), phosphatidylserines 
(PSs), lysophosphatidylserines (LPSs), phosphatidylethanolamines (PEs), 
lysophosphatidylethanolamines (LPEs), phosphatidylinositols (PIs), 
phosphatidylglycerols (PGs) and sphingomyelin (SM) (Table A.2).  
PC were identified as [M+CH3COO]- ions in LC-MS spectra of all conditions. The 
most abundant PC molecular specie identified was PC(34:1) at m/z 818.2 (Figure S.8). 
Interestingly this PC specie was also observed as the most abundant in the lipidome of 
myoblast cells. Significantly alterations in PC molecular profile were observed after 
comparing PC profile from exosomes of starvation and ischemia conditions, with 
control and also between both conditions (Figure 13). A significant increase of PC(30:1) 
and PC(32:1) and a decrease of PC(38:6) were observed for ischemia in comparison 
with control. Comparing exosomes released by starved cells with control we observed 
an increase of PC(32:5), PC(34:4), PC(38:6) and PC(38:2) and a decrease of PC(30:1), 
PC(34:1), PC(36:2) and PC(36:1). We have also observed alterations in alkylacyl PC 
molecular species namely an increase of PC(O-32:2and a decrease of PC(O-34:1) and 
PC(O-36:0). The alkylacyl PC molecular species PC(O-40:6) and PC(O-40:5) increase 
in exosomes from starved cell in comparison with exosomes from ischemic myoblast 
cells. 
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Figure 13. Phosphatidylcholine (PC) molecular species content of exosomes released 
by untreated myoblast cells (control) and associated with ischemia and starvation 
analyzed by HPLC-MS in negative mode. Identification of PC molecular species with 
the indication of the C:N (carbon:unsaturation). 
Seven LPC molecular species were identified as [M+CH3COO]- ions. For control 
and starvation groups the most abundant LPC molecular specie was LPC(18:0) at m/z 
582.2 while for starvation the most abundant LPC molecular specie was LPC(16:1) at 
m/z 552.2 (Figure S.9). Comparing LPC profile of exosomes release during starvation 
with control and with ischemia, it was possible to see a significant increase in 
LPC(16:1) and  a decrease in LPC(18:4) and LPC(18:0) (Figure 14). No differences 
were observed in LPC molecular profile between ischemia and control. 
 
Figure 14. Lysophosphatidylcholine (LPC) molecular species content of exosomes 
released by untreated myoblast cells (control) and associated with ischemia and 
starvation analyzed by HPLC-MS in negative mode. Identification of LPC molecular 
species with the indication of the C:N (carbon:unsaturation). 
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The SM were also identified by [M+CH3COO]- ions. The ion at m/z 761.2 
corresponding to SM(34:1) is the major molecular specie identified in all conditions 
(Figure S.10). An increase of SM(34:1) and a decrease of SM(42:1) were observed for 
ischemia in comparison with control and with starvation. We have also observed for 
ischemia a decrease in SM(40:1) and SM(42:2) only in comparison with control. For 
starvation, we observed an increase in SM(38:2) in comparison with control and with 
ischemia. We have also observed an increase in SM(36:1) together with a decrease in 
SM(34:0) for starvation in comparison with ischemia (Figure 15). 
 
Figure 15. Sphingomyelin (SM) molecular species content of exosomes released by 
untreated myoblast cells (control) and associated with ischemia and starvation analyzed 
by HPLC-MS in negative mode. Identification of SM molecular species with the 
indication of the C:N (carbon:unsaturation). 
The PI molecular species were analyzed in negative mode as [M-H]- ions. The major 
PI molecular specie identified for exosomes from control conditions was PI(40:7) while 
for exosomes released from starved cells the major PI molecular specie identified was 
PI(34:4) at m/z 829.8. For exosomes in ischemia, both ions presented the same 
abundance (Figure S.11) A significant increase of PI(34:4), PI(40:4) and a decrease in 
PI(38:4) and PI(40:7) were observed for exosomes in ischemia and starvation in 
comparison with control. Additionally, we observed an increase in PI(36:3) for ischemia 
and an increase in PI(34:3) together with a decrease in PI(38:1) for starvation in 
comparison with control. The molecular specie PI(34:5) showed a decrease in starvation 
in comparison with ischemia (Figure 16). 
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Figure 16. Phosphatidylinositol (PI) molecular species content of exosomes released by 
untreated myoblast cells (control) and associated with ischemia and starvation analyzed 
by HPLC-MS in negative mode. Identification of PI molecular species with the 
indication of the C:N (carbon:unsaturation). 
  The PG molecular species were  identified as [M-H]- ions and  PG(38:6) at m/z 
793.4 was the major PG molecular specie in exosomes from control while for ischemia 
and starvation the major PG was PG(36:2) at m/z 773.6 (Figure S.12). An increase in 
PG(34:2) and PG(36:4) and a decrease in PG(38:6) and PG(38:5) were observed for 
exosomes released by ischemic cells in comparison with exosomes from control and 
from starved cells. The molecular species PG(34:0) and PG(36:6) decrease for both 
conditions in comparison with control. An increase of PG(32:1), PG(34:2), PG(36:2) 
and PG(38:2) and a decrease of PG(34:1) and PG(36:3) were observed for exosomes 
from starved cells in comparison with control. Interestingly PG(34:3) showed opposite 
deviation, namely increasing for ischemia while decreasing for starvation (Figure 17). 
 
Figure 17. Phosphatidylglycerol (PG) molecular species content of exosomes released 
by untreated myoblast cells (control) and associated with ischemia and starvation 
analyzed by HPLC-MS in negative mode. Identification of PG molecular species with 
the indication of the C:N (carbon:unsaturation). 
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 The molecular species of PE and LPE were identified as [M-H]- ions, but 
quantification was umpired by the  low peak intensity in these classes identify some 
molecular species represented in Table A.2. 
The molecular species of PS and LPS were also identified as [M-H]- ions but for the 
same reason were not quantified. However they were identified and are showed in Table 
A.2. 
Overall, the same molecular species were found for each PL class from exosomes in 
control and either in ischemia and starvation. The differences identified so far are 
summarized in Table 2. It must be reported that data from exosomes need to be 
confirmed with more replicates. 
 
Table 2. Resume of the alterations observed for exosomes in the molecular species of 
PC, LPC, SM, PI and PG comparing control with ischemia, control with starvation and 
starvation with ischemia. 
Class Molecular species Control vS Ischemia Control vS Starvation Starvation vS Ischemia 
PC 
30:1    
32:5    
32:1    
34:4    
34:1    
36:2    
36:1    
38:6    
38:2    
O-32:2    
O-34:1    
O-36:0    
O-40:6    
O-40:5    
LPC 
16:1    
18:4    
18:0    
SM 
34:1    
34:0    
36:1    
38:2    
40:1    
42:2    
42:1    
PI 
34:5    
34:4    
34:3    
36:3    
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38:5    
38:4    
38:1    
40:7    
40:4    
PG 
32:1    
34:3    
34:2    
34:1    
34:0    
36:6    
36:4    
36:3    
36:2    
38:6    
38:5    
38:2    
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Discussion and Conclusion 
This study evaluated the alterations in PL profile of myoblast cells induced by 
starvation and ischemia conditions, using a modern lipidomic approach. Both conditions 
induced significant alterations in PLs classes levels namely decrease in PCs in ischemia 
and PS related content in starvation conditions. 
The fatty acid profile analysis of the studied myoblast cell line revealed an increase 
in FA 16:0 and 18:0 and a decrease in FA 18:1 in ischemic cells while in starved cells a 
decrease of FA 20:4 was observed. This dissimilar deviation of FA profile may reflect 
the different pathways adopted by the cells to cell death or cell survival namely to 
activate apoptotic pathway or autophagic pathways respectively. In fact an increase of 
serum FA 16:0 and 18:0 were reported in patients that have higher predisposition to 
have a coronary event in comparison with health volunteers [127]. Arachidonic acid FA 
20:4 is the main precursor of pro inflammatory mediators, prostaglandins and 
leukotrienes, and thus the observed decrease of fatty acid 20:4 in starved cells may be 
an adaptive response of cell in order to unpair the release of these pro inflammatory 
mediators and thus preventing the enhance of pro inflammatory that triggers apoptosis 
and cell death [128]. This could be one of the routes that can be modulated by starvation 
towards cell. Decrease of arachidonic pro inflammatory mediators will reduce the 
inflammation and will have a beneficial effect in CVD. In fact, inflammation is 
recognized to be a major underlying mechanism of cardiovascular diseases [129].  
In the case of ischemia, a severe form of starvation [12] due to simultaneous 
deprivation of oxygen and nutrients, we were not able to identify significant alterations 
in PC total content. However, a decrease in PC(36:2) - PC( 18:0/18:2) and  
PC(18:1/18:1) - and an increase in PC(34:1) - PC ( 16:0; 18:1) - were observed. This 
shift is in accordance with the data reported from GC-MS analysis that in ischemia also 
showed an increase in C16:0 and C18:0 fatty acyl chains and a decrease in C16:1 and 
C18:1 in comparison with the control. Since PC is the most abundant PL class in 
mammalian cells, this lowering in the degree of unsaturation suggests modifications in 
cell membrane. The membrane fluidity is determined by the van der Waals forces 
between fatty acids incorporated into cell membrane phospholipids. These forces 
depend on the structure of the fatty acid and thereby the longer and saturated the fatty 
acid chain is, the higher the van der Waals forces are and the lower the membrane 
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fluidity is [130]. The decrease in fluidity interferes with the function of receptors in the 
membrane, affecting signal transduction [131]. 
In starvation, a significant decrease in the PCs levels together with a decreased in the 
levels of the molecular specie PC(34:1) - PC( 16:0/18:1) - was observed in comparison 
with the control group. Under this condition, the cell tries to survive and adapts cellular 
lipid flow and storage to changing nutrient availability and metabolic need [132]. In 
starved cells, autophagy is strongly induced and represents the most important 
mechanism for survival and for maintenance of cardiac functions of the heart [133]. 
The molecular specie PC(34:1) – PC(16:0/18:1) - increased in ischemia and 
decreased in starvation. This is specific marker that could be used to accesses of the 
undergoing process in the cell. It was reported that a PC(16:0/18:1) is a physiologically 
relevant endogenous PPARα ligand [134]. This nuclear receptor is known for 
modulation of inflammatory pathways possessing relevant anti-inflammatory properties 
[135]. The decrease of PC(34:1) in starvation suggests that this molecular specie is 
being used to activate PPARα to promote cell survival.  
LPC are derived from phosphatidylcholine degradation by phospholipase A2 (PLA2), 
which removes the fatty acid linked to the sn2 position. LPCs are quickly metabolized 
and last shortly in vivo. They can insert into the plasmatic membrane and influence 
several pathways, namely as immunomodulatory agents [136]. In this study, it is 
possible to see an increase in LPC species bearing C18:0, in both conditions, and a 
decrease in LPC(18:1) and LPC(16:0) decreased only in ischemia. The decrease of the 
molecular species LPC(16:0) and LPC(18:1) in ischemia may be associated with the 
increase of the molecular specie PC(34:1) once it is assigned as PC(16:0/18:1).  
Since the activity of PLA2 is usually upregulated in inflammatory environments 
[137], we suppose that PLA2 acts upon PC(36:2) – PC(18:0/18:2) - releasing LPC(18:0) 
and contributing to the higher levels of this LPC molecular specie. This increase in 
LPC(18:0) as well as the increase in the molecular specie PC(34:1) are related with the 
reported anti-inflammatory role for PC and LPC [136].  
We have also identified a decrease in the levels of SM(34:1) in starvation. In fact 
sphingolipids have been reported as important player in autophagy and also in 
apoptosis. The decrease of SM may downregulate the enzymatically conversion to 
ceramide (Cer), a well-known pro apoptotic molecule and thus preventing cell death 
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[138]. Sphingolipid, particularly in lipid rafts, are implicated in signal transduction from 
cell surface receptors to intracellular signaling machinery [139]. Hence alterations in 
SM metabolism will affect survival signaling. 
PE is the second most abundant phospholipid in mammalian cell membranes and 
changes in PE may affect membrane structure and curvature [140]. PE plays an 
important role in the heart since a decrease in PE causes cell damage after periods of 
ischemia/reperfusion [141].While the decrease in PE accelerate cell death, the increase 
enhances autophagic flux and extends lifetime of mammalian cells in culture [142]. In 
our study, we observed an increase of PE(34:1) in ischemic and in starved myoblast 
cells.  
PS is the most abundant negatively charged phospholipid in eukaryotic membranes 
[143]. Its extracellular exposure is, among other functions, essential in the recognition 
and clearance of apoptotic cells [144]. During apoptosis and the oxidative stress 
resulting from the inflammation, there is the release of cytochrome c from mitochondria 
that promote PS peroxidation followed by PS externalization [145]. In this study, we 
have observed a decrease in PS content of myoblast cells associated with ischemia. The 
observed decrease could be due to the PS peroxidation which triggers apoptosis. On the 
other hand, in starvation the molecular specie PS(36:1) showed an increase in 
comparison with control. Recently PS is being associated with anti-inflammatory roles, 
and thus considered key players in controlling inflammatory response [146]. In addition 
PS anti-inflammatory were associated with beneficial impact in myocardial infarction 
by attenuating the consequences and improve prognostic and cardiac repair [147]. 
PIs are important precursors of signaling molecules that regulate metabolic process. 
In this study we observed a decrease of PI(38:5) in both conditions in comparison with 
control and a decrease of PI(36:2) in ischemia in comparison with starvation. PI is a 
precursor of phosphoinositides (PIPs), and their decrease may be due to the 
upregulation of PIPs. That play a fundamental role in regulation of cell survival 
controlling membrane traffic and permeability [148]. It is known that PI3P is required 
for autophagy and among other roles is involved in the biogenesis of autophagosome 
[149]. 
In our study, we were not able to identify significant alterations in PG amounts 
between control and either ischemia or starvation conditions.  
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A communication between different cell types plays a central role in adaptative 
responses of the heart to stress. Recently, exosomes released by myoblast cells have 
been implicated as a new tool for cardiac cell communication allowing them to 
exchange biological messages to other cell types of the heart such as endothelial cells 
and fibroblasts [150]. Till now only DNA, miRNA and proteins were studied to try to 
understand this intercellular communication [151,152]. However lipids are well known 
signaling molecules and for sure have an important role in cell exosomes cross talk. 
No study reported so far the lipid analysis of exosomes released by a myoblast cell 
line. Lipidomic analysis of exosomes were reported only for exosomes released by 
guinea-pig reticulocytes [153], by a B lymphocyte cell line [154], by human mast cells 
and dendritic cells [155], and by PC-3 prostate cancer cells [81]. 
In our work, we studied the lipidome of exosomes released by the myoblast cell line 
H9c2 and evaluated the alterations in PL profile of this exosomes associated with 
starvation and ischemia. 
Due to the difficulty in obtaining exosomes we only studied the lipid profile of only 
one sample and were performed analytical replicates. The lipid classes identified by LC-
MS for exosomes released by myoblast cells were SM, PC, PE, PS, PI, PG, LPC, LPE 
which is in agreement with what was already identified for exosomes released and 
isolated from other cell lines [81,155]. The analysis of LC-MS allowed us to identified 
alterations in specific phospholipid molecular species. It is noteworthy that these results 
are only preliminary and that the increase in the number of samples may change a bit 
the differences that we have seen so far. 
Our results on exosomes showed a decrease in PS and PE together with an increase 
in LPE and LPS in exosomes in comparison with cells. This suggests that lyso species 
are somehow associated with exosomes role namely in the intercellular communication. 
In fact, lysophospholipid such as LPC, LPE and LPS exert functions as lipid mediators 
through G protein-couple receptors specific to each lysophospholipid [156]. We have 
also observed a deviation between the lipidome of exosomes released upon ischemia 
and starvation for all lipid classes. Some differences matched the ones observed in cells, 
for example the decrease in PC(34:1) in starvation, but others were different. 
Differences in lipidome of exosomes released upon ischemia and released upon 
starvation may be associated with the different responses that each one of them is going 
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to enhance after release. Since we only performed lipidomic analysis for a smaller 
sample of exosomes, it requires further studies to validate the results already obtained 
and to identify PE and PS molecular species, quantify lipid classes and analyze the fatty 
acids profile as performed for myoblast cell line lipidomic analysis. 
In conclusion, our work showed changes of lipid homeostasis in ischemic and 
starved cells suggesting that lipids are key tools for evaluation of the cell fate, either cell 
death or recovery. This will be suitable to improve diagnosis and prognostic of 
cardiovascular diseases particularly acute myocardial infarction. 
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Figure S. 1. MS spectra of phosphatidylcholine (PC) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated myoblast cells (control) and after 
being subjected to ischemia and starvation. 
 
 
Figure S. 2. MS spectra of lysophosphatidylcholine (LPC) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated myoblast cells (control) and after 
being subjected to ischemia and starvation. 
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Figure S. 3. MS spectra of sphingomyelin (SM) molecular species obtained by HPLC-
MS analysis in negative mode for untreated myoblast cells (control) and after being 
subjected to ischemia and starvation. 
 
Figure S. 4. MS spectra of phosphatidylethanolamine (PE) molecular species obtained 
by HPLC-MS analysis in negative mode for untreated myoblast cells (control) and after 
being subjected to ischemia and starvation. 
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Figure S. 5. MS spectra of phosphatidylserine (PS) molecular species obtained by HPLC-
MS analysis in negative mode for untreated myoblast cells (control) and after being 
subjected to ischemia and starvation. 
 
Figure S. 6. MS spectra of phosphatidylinositol (PI) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated myoblast cells (control) and after 
being subjected to ischemia and starvation. 
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Figure S. 7. MS spectra of phosphatidylglycerol (PG) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated myoblast cells (control) and after 
being subjected to ischemia and starvation. 
 
Figure S. 8. MS spectra of phosphatidylcholine (PC) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated exosomes released by myoblast cells 
(control) and after being subjected to ischemia and starvation. 
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Figure S. 9. MS spectra of lysophosphatidylcholine (LPC) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated exosomes released by myoblast cells 
(control) and after being subjected to ischemia and starvation. 
 
Figure S. 10. MS spectra of sphingomyelin (SM) molecular species obtained by HPLC-
MS analysis in negative mode for untreated exosomes released by myoblast cells (control) 
and after being subjected to ischemia and starvation. 
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Figure S. 11. MS spectra of phosphatidylinositol (PI) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated exosomes released by myoblast cells 
(control) and after being subjected to ischemia and starvation. 
 
Figure S. 12. MS spectra of phosphatidylglycerol (PG) molecular species obtained by 
HPLC-MS analysis in negative mode for untreated exosomes released by myoblast cells 
(control) and after being subjected to ischemia and starvation. 
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Table A. 1 Lipid molecular species of PC, LPC, PE, PS, PI, PG and SM identified in 
myoblast cell line H9c2 submitted to ischemia and starvation and acquired using an 
automated HPLC-MS. Identification with m/z (mass/charge), corresponding C:N 
(carbon:unsaturation) and fatty acid composition. 
 
Class m/z C:N Fatty Acids 
PC 
DIACYL 
762.3 30:1 14:0/16:1 
764.3 30:0 14:0/16:0 
790.3 32:1 14:0/18:1 and 16:0/16:1 
792.2 32:0 14:0/18:0 and 16:0/16:0 
814.2 34:3 16:0/18:3 and 16:1/18:2 
816.2 34:2 16:0/18:2 and 16:1/18:1 
818.3 34:1 16:0/18:1 and 16:/18:0 
820.2 34:0 16:0/18:0 
836.2 36:6 16:2/20:4 
840.3 36:4 16:0/20.4 and 18:1/18:3 and 18:2/18:2 
842.3 36:3 16:0/20:3 and 18:0/18:3 and 18:1/18:2 
844.3 36:2 16:0/20:3 and 18:0/18:2 and 18:1/18:1 
846.3 36:1 16:0/20:1 and 18:0/18:1 
848.3 36:0 18:0/18:0 
864.3 38:6 18:2/20:4 
866.1 38:5 18:1/20:4 
868.3 38:4 
18:0/20:4 and 18:1/20:3 and 18:2/20:2 
and 18:3/20:1 and 18:4/20:0 
870.3 38:3 18:0/20:3 and 18:1/20:2 and 18:2/20:1 
872.3 38:2 18:0/20:2 and 18:1/20:1 
890.3 40:7 20:3/20:4 
892.2 40:6 20:2/20:4 and 20:3/20:3 
ALKYLACYL 
776.3 32:1 O-16:0/16:1 
802.2 34:2 O-16:0/18:2 and O-16:1/18:1 
804.3 34:1 O-16:0/18:1 and O-16:1/18:0 
828.3 36:3 
O-16:0/20:3 and O-16:1/20:2 and O-
18:0/18:3 and O-18:1/18:2 
830.3 36:2 
O-16:0/20:2 and O-16:1/20:1 and O-
18:0/18:2 and O-18:1/18:1 
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832.3 36:1 
O-16:0/20:1 and O-16:1/20:0 and O-
18:0/18:1 
LPC 
DIACYL 
552.0 16:1 16:1 
554.1 16:0 16:0 
578.2 18:2 18:2 
580.1 18:1 18:1 
582.1 18:0 18:0 
ALKYLACYL 
566.0 18:0 O-18:0 
PE 
 
DIACYL 
716.2 34:1 16:0/18:1 and 16:1/18:0 
736.4 36:5 16:0/20:5 and 16:1/20:4 
738.3 36:4 16:0/20:4 and 16:1/20:3 
740.4 36:3 
16:0/20:3 and 16:1/20:2 and 18:0/18:3 
and 18:1/18:2 
742.4 36:2 
18:0/18:2 and 18:1/18:1 and 16:0/20:2 
and 16:1/20:1 
744.3 36:1 
16:0/20:1 and 18:0/18:1 and 16:1/20:0 
and 14:0/22:1 
746.4 36:0 14:0/22:0 and 16:0/20:0 and 18:0/18:0 
762.3 38:6 18:1/20:5 and 18:2/20:4 
764.4 38:5 18:0/20:5 and 18:1/20.4 and 18:2/20:3 
766.4 38:4 16:0/22:4 and 18:0/20:4 and 18:1/20:3 
768.3 38:3 18:0/20:3 and 18:1/20:2 and 18:2/20:1 
772.4 38:1 18:0/20:1 
774.3 38:0 18:0/20:0 and 16:0/22:0 
792.4 40:5 
18:0/22:5 and 18:1/22.4 and 20:1/20:4 
and 20:2/20:3 
794.3 40:4 
18:0/22:4 and 18:1/22:3 and 20:0/20:4 
and 20:1/20:3 
796.2 40:3 
18:0/22:3 and 18:1/22:2 and 20:0/20:3 
and 20:1/20:2 
798.1 40:2 
18:0/22:2 and 18:1/22:1 and 20:0/20:2 
and 20:1/20:1 
ALKYLACYL 
700.4 34:2 O-16:0/18:2 and O-16:1/18:1 
702.4 34:1 O-16:0/18:1 and O-16:1/18:0 
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722.3 36:5 
O-16:0/20:5 and O-16:1/20:4 and O-
18:1/18:4 
724.4 36:4 
O-16:0/20:4 and O-16:1/20:3 and O-
18:0/18:4 and O-18:1/18:3 
726.4 36:3 
O-16:1/20:2 and O-18:0/18:3 and O-
18:1/18:2 
728.5 36:2 O-18:0/18:2 and O-18:1/18:1 
748.4 38:6 
O-16:0/22:6 and O-16:1/22:5 and O-
18:1/20:5 
750.4 38:5 
O-16:0/22:5 and O-16:1/22:4 and O-
18:0/20:5 and O-18:1/20:4 
752.4 38:4 
O-16:1/22:4 and O-18:0/20:4 and O-
18:1/20:3 
774.3 40:7 O-18:1/22:6 
776.3 40:6 O-18:0/22:6 and O-18:1/22:5 
778.4 40:5 O-18:1/22:4 
PS 
DIACYL 
758.3 34:2 16:0/18:2 and 16:1/18:1 
760.3 34:1 16:0/18:1 and 16:1/18:0 
782.3 36:4 16:0/20:4 and 16:1/20:3 
786.3 36:2 16:0/20:2 and 18:0/18:2 and 18:1/18:1 
788.4 36:1 16:0/20:1 and 16:1/20:0 and 18:0/18:1 
810.4 38:4 
16:0/22:4 and 18:0/20:4 and 18:1/20:3 
and 18:2/20:2 and 18:3/20:1 and 
18:4/20:0 
812.3 38:3 18:0/20:3 
814.1 38:2 16:1/22:1 and 18:0/20:2 and 18:1/20:1 
830.3 40:8 20:4/20:4 
834.3 40:6 
18:0/22:6 and 18:1/22:5 and 18:2/22:4 
and 20:1/20:5 and 20:2/20:4 and 
20:3/20:3 
836.3 40:5 
16:1/24:4 and 18:0/22:5 and 18:1/22:4 
and 20:1/20:4 and 20:2/20:3 
PI 
DIACYL 
833.4 34:2 16:0/18:2 and 16:1/18:1 
835.4 34:1 16:0/18:1 and 16:1/18:0 
837.4 34:0 16:0/18:0 
857.4 36:4 16:0/20:4 and 18:0/18:4 and 18:1/18:3 
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859.4 36:3 16:0/20:3 and 18:0/18:3 and 18:1/18:2 
861.5 36:2 16:0/20:2 and 18:0/18:2 and 18:1/18:1 
863.4 36:1 18:0/18:1 
883.4 38:5 16:0/22:5 and 18:0/20:5 and 18:1/20:4 
885.4 38:4 
16:0/22:4 and 18:0/20:4 and 18:1/20:3 
and 18:2/20:2 and 18:3/20:1 and 
18:4/20:0 
887.4 38:3 
18:0/20:3 and 18:1/20:2 and 18:2/20:1 
and 18:3/20:0 
889.5 38:2 18:0/20:2 and 18:1/20:1 
891.4 38:1 18:0/20:1 
907.0 40:7 18:1/22:6 and 18:2/22:5 and 18:3/22:4 
909.4 40:6 18:0/22:6 and 18:1/22:5 and 20:2/20:4 
911.3 40:5 
18:0/22:5 and 18:1/22:4 and 20:0/20:5 
and 20:1/20:4 and 20:2/20:3 
913.4 40:4 18:0/22:4 and 20:0/20:4 
ALKYLACYL 
819.3 34:2 O-16:0/18:2 and O-18:1/16:1 
821.3 34:1 O-16:0/18:1 and O-16:1/18:0 
907.0 40:0 O-18:0/22:0 
PG 
 
DIACYL 
745.4 34:2 16:0/18:2 and 16:1/18:1 
747.4 34:1 16:0/18:1 and 16:0/18:0 
771.3 36:3 18:1/18:2 
773.4 36:2 16:0/20:2 and 18:0/18:2 and 18:1/18:1 
775.4 36:1 16:0/20:1 and 18:0/18:1 
SM 
 
m/z C:N Sphingoid Base Fatty Acid 
761.2 34:1 d18:1 16:0 
763.2 34:0 d18:0 16:0 
789.3 
 
36:1 d18:0 18:1 
 d18:1 18:0 
791.3 36:0 d18:0 18:0 
815.3 38:2 d18:1 20:1 
817.3 38:1 d18:1 20:0 
871.3 42:2 d18:1 24:1 
873.3 
 
42:1 d18:0 24:1 
 d18:1 24:0 
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Table A. 2. Lipid molecular species of PC, LPC, PE, LPE, PS, LPS, PI, PG and SM 
identified in exosomes released by myoblast cell line H9c2 submitted to ischemia and 
starvation and acquired using an automated HPLC-MS. Identification with m/z 
(mass/charge), corresponding C:N (carbon:unsaturation) and fatty acid composition. 
 
Classes m/z C:N Fatty Acid 
PC 
DIACYL 
762.3 30:1 14:0/16:1 
782.4 32:5 14:1/18:4 
790.3 32:1 
16:0/16:1 and 14:0/18:1 and 
12:0/20:1 
812.3 34:4 
14:0/20:4 and 16:0/18:4 and 
16:1/18:3 
818.2 34:1 16:0/18:1 and 16:1/18:0 
844.3 36:2 
16:0/20:3 and 18:0/18:2 and 
18:1/18:1 
846.3 36:1 16:0/20:1 and 18:0/18:1 
864.3 38:6 18:2/20:4 and 18:4/20:2 
866.3 38:5 18:1/20:4 
868.3 38:4 18:0/20:4 and 18:1/20:3 
872.2 38:2 18:0/20:2 and 18:1/20:1 
ALKYLACYL 
774.3 32:2 O-16:1/16:1 
778.3 32:0 
O-14:0/18:0 and 
O-16:0/18:0 
804.2 34:1 
O-16:0/18:1 and 
O-16:1/18:0 
832.3 36:1 
O-16:0/20:1 and O-16:1/20:0 and 
O-18:0/18:1 
834.3 36:0 O—16:0/20:0 
878.3 40:6 
O-18:0/22:6 and 
O-18:1/22:5 
880.3 40:5 
O-18:0/22:5 and 
O-18:1/22:4 
886.1 40:2 
O-18:0/22:2 and 
O-18:1/22:1 
LPC 
DIACYL 
552.2 16:1 16:1 
554.2 16:0 16:0 
574.1 18:4 18:4 
580.2 18:1 18.1 
582.2 18:0 18:0 
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ALKYLACYL 
566.5 18:1 O-18:1 
568.3 18:0 O-18:0 
PE 
DIACYL 
736.7 36:5 
16:0/20:5 and 16:1/20:4 and 18:1/18:4 
and 18:2/18:3 
738.3 36:4 
16:0/20:4 and 16:1/20:3 and 18:0/18:4 
and 18:1/18:3 and 18:2/18:2 
744.4 36:1 16:0/20:1 and 18:0/18:1 
762.3 38:6 18:1/20:5 and 18:2/20:4 and 18:3/20:3 
766.4 38:4 18:0/20:4 and 18:1/20:3 and 18:2/20:2 
ALKYLACYL 
748.4 38:6 
O-16:0/22:6 and 
O-16:1/22:5 
LPE 
DIACYL 
424.1 14:0 14:0 
474.1 18:3 18:3 
500.1 20:4 20:4 
526.2 22:5 22:5 
532.1 22:2 22:2 
536.2 22:0 22:0 
PS 
DIACYL 
838.3 40:4 
18:0/22:4 and 18:2/22:2 and 18:3/22:1 
and 18:4/22:0 and 20:0/20:4 and 
20:1/20:3 and 20:2/20:2 
ALKYLACYL 
748.3 34:0 O-16:0/18:0 
LPS 
DIACYL 
468.3 14:0 14:0 
496.2 16:0 16:0 
518.2 18:3 18:3 
522.3 18:1 18:1 
PI 
DIACYL 
827.6 34:5 16:2/18:3 
829.8 34:4 16:0/18:4 and 16:1/18:3 
831.7 34:3 16:0/18:3 and 16:1/18:2 
833.8 34:2 16:0/18:2 and 16:1/18:1 
835.4 34:1 16:0/18:1 and 16:1/18:0 
837.2 34:0 16:0/18:0 
857.7 36:4 16:0/20:4 and 18:0/18:4 and 18:1/18:3 
859.8 36:3 16:0/20:3 and 18:0/18:3 and 18:1/18:2 
861.8 36:2 16:0/20:2 and 18:0/18:2 and 18:1/18:1 
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863.8 36:1 18:0/18:1 
881.4 38:6 16:0/22:6 
883.6 38:5 18:0/20:5 and 18:1/20:4 
885.6 38:4 18:0/20:4 and 18:1/20:3 
887.8 38:3 18:0/20:3 and 18:1/20:2 and 18:2/20:1 
891.5 38:1 18:0/20:1 
907.3 40:7 18:1/22:6 
911.7 40:5 
18:0/22:5 and 18:1/22:4 and 20:1/20:4 
and 20:2/20:3 
913.8 40:4 18:0/22:4 and 20:0/20:4 
915.8 40:3 18:0/22:3 and 20:1/20:2 
917.7 40:2 20:0/20:2 
PG 
DIACYL 
719.5 32:1 16:0/16:1 
721.3 32:0 16:0/16:0 
743.5 34:3 16:1/18:2 and 16:2/18:1 
745.6 34:2 16:0/18:2 and 16:1/18:1 
747.5 34:1 16:0/18:1 and 16:1/18:0 
749.5 34:0 16:0/18:0 
765.3 36:6 18:2/18:4 and 18:3/18:3 
767.4 36:5 16:1/20:4 and 18:1/18:4 and 18:2/18:3 
769.4 36:4 
16:0/20:4 and 16:1/20:3 and 18:1/18:3 
and 18:2/18:2 
771.3 36:3 16:0/20:3 and 16:1/20:2 and 18:1/18:2 
773.6 36:2 16:0/20:2 and 18:0/18:2 and 18:1/18:1 
775.6 36:1 16:0/20:1 and 18:0/18:1 
793.4 38:6 18:2/20:4 and 18:3/20:3 
795.3 38:5 18:2/20:3 and 18:3/20:2 and 18:4/20:1 
801.7 38:2 18:0/20:2 and 18:1/20:1 
803.3 38:1 18:0/20:1 
SM 
 
 
 
 
 
 
 
 
m/z C:N Sphingoid Base Fatty Acid 
761.2 34:1 d18:1 16:0 
763.3 34:0 d18:0 16:0 
787.3 36:2 d18:1 18:1 
789.2 36:1 
d18:1 18:0 
d18:0 18:1 
815.1 38:2 d18:1 20:1 
845.3 40:1 d18:1 22:0 
871.3 42:2 d18:1 24:1 
873.4 42:1 
d18:1 24:0 
d18:0 24:1 
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